1
|
Paccoud O, Desnos-Ollivier M, Persat F, Demar M, Boukris-Sitbon K, Bellanger AP, Bonhomme J, Bonnal C, Botterel F, Bougnoux ME, Brun S, Cassaing S, Cateau E, Chouaki T, Cornet M, Dannaoui E, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Poirier P, Ranque S, Roosen G, Rouges C, Roux AL, Sasso M, Alanio A, Lortholary O, Lanternier F. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020). Clin Microbiol Infect 2024:S1198-743X(24)00162-9. [PMID: 38556212 DOI: 10.1016/j.cmi.2024.03.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 02/20/2024] [Accepted: 03/24/2024] [Indexed: 04/02/2024]
Abstract
OBJECTIVES We aimed to describe features and outcomes of cryptococcosis among HIV-seronegative individuals in a large surveillance network for cryptococcosis in France. METHODS We included incident cases of cryptococcosis in HIV-seronegative individuals from 2005 to 2020. We compared patient characteristics, disease presentations, cryptococcal antigen results, and induction antifungal treatments according to underlying disease. We examined factors associated with 90-day mortality. Among patients with disseminated infections, we investigated whether receipt of flucytosine and polyene combination was associated with lower mortality. RESULTS Among 652 individuals, 209 (32.1%) had malignancy, 130 (19.9%) were solid-organ transplant recipients, 204 (31.3%) had other immunocompromising conditions, and 109 (16.7%) had no reported underlying factor. The commonest presentations were disseminated infections (63.3%, 413/652) and isolated pulmonary infections (25.3%, 165/652). Solid-organ transplant patients were most likely to have disseminated infections and a positive serum cryptococcal antigen result. Patients with malignancy were older and less likely to receive a flucytosine-containing regimen for disseminated infections than others (58.7%, 78/133 vs. 73.2%, 194/265; p 0.029). The crude 90-day case-fatality ratio was 27.2% (95% CI, 23.5%-31.1%). Age ≥60 years (aOR: 2.75 [1.78-4.26]; p < 0.001), meningitis/fungaemia (aOR: 4.79 [1.80-12.7]; p 0.002), and malignancy (aOR: 2.4 [1.14-5.07]; p 0.02) were associated with higher 90-day mortality. Receipt of flucytosine and polyene combination was associated with lower 90-day mortality (aOR: 0.40 [0.23-0.71]; p 0.002) in multivariable analysis and inverse probability of treatment weighted analysis (aOR: 0.45 [0.25-0.80]; p 0.006). DISCUSSION HIV-seronegative individuals with cryptococcosis comprise a wide range of underlying conditions with different presentations and outcomes, requiring a tailored approach to diagnosis and management.
Collapse
Affiliation(s)
- Olivier Paccoud
- Université Paris Cité, Department of Infectious Diseases and Tropical Medicine, Necker - Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), IHU Imagine, 75014 Paris, France.
| | - Marie Desnos-Ollivier
- Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France
| | - Florence Persat
- UR3738 Centre pour l'lnnovation en Cancérologie de Lyon, Team Inflammation and Immunity of the Respiratory Epithelium, Claude Bernard University-Lyon 1, 69495 Pierre Bénite, France; Department of Medical Mycology and Parasitology, Institute of Infectious Agents, Croix-Rousse Hospital, Hospices Civils de Lyon, 69004 Lyon, France
| | - Magalie Demar
- Laboratoire Hospitalo-Universitaire de Parasito-Mycologie, Centre hospitalier de Cayenne Guyane, Cayenne, France
| | - Karine Boukris-Sitbon
- Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France
| | - Anne-Pauline Bellanger
- CHU de Besançon, Laboratoire de Parasitologie-Mycologie, UMR Chrono-Environnement/CNRS 6249, F-25000, Besançon, France
| | - Julie Bonhomme
- Laboratoire de Parasitologie-Mycologie, CHU de Caen, ToxEMAC-ABTE, Unicaen Université Normandie, Caen, France
| | - Christine Bonnal
- Laboratory of Parasitology-Mycology, Bichat-Claude Bernard University Hospital, AP-HP, 75018 Paris, France
| | - Françoise Botterel
- Unité de Parasitologie - Mycologie, Département des agents infectieux, AP-HP, Dynamyc research Unit, UPEC, France
| | - Marie-Elisabeth Bougnoux
- Unité de Parasitologie-Mycologie, Service de Microbiologie Clinique, Hôpital Necker-Enfants-Malades, AP-HP, Paris, France; Institut Pasteur, Université Paris Cité, INRAE USC2019, Unité Biologie et Pathogénicité Fongiques, Paris, France
| | - Sophie Brun
- Parasitology-Mycology Department, Avicenne Hospital, AP-HP, Bobigny, France
| | - Sophie Cassaing
- Department of Parasitology and Mycology, Toulouse University Hospital, Restore-FLAMES, Toulouse III University, France
| | - Estelle Cateau
- Laboratoire de Parasitologie-Mycologie - CHU de Poitiers, Ecologie et Biologie des Interactions UMR CNRS 7267, France
| | - Taieb Chouaki
- Service de Parasitologie Mycologie Médicales, CHU Amiens Picardie 80054, Amiens, France; Inserm U1285, Univ. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France
| | - Muriel Cornet
- Université Grenoble Alpes, CNRS, UMR 5525, CHU Grenoble Alpes, VetAgro Sup, Grenoble INP, TIMC, 38000 Grenoble, France
| | - Eric Dannaoui
- Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France; Unité de Parasitologie-Mycologie, Service de Microbiologie Clinique, Hôpital Necker-Enfants-Malades, AP-HP, Paris, France
| | - Nicole Desbois-Nogard
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | | | - Loïc Favennec
- French National Cryptosporidiosis Reference Center, CHU de Rouen, Rouen, Normandie, France; EA 7510, UFR Santé, University of Rouen Normandy, Rouen, France
| | - Arnaud Fekkar
- AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013, Paris, France; Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, F-75013, Paris, France
| | - Frederic Gabriel
- Laboratoire de Parasitologie-Mycologie, CHU de Bordeaux, F-33000 Bordeaux, France
| | - Jean-Pierre Gangneux
- Université de Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Laboratory of Parasitology and Medical Mycology, European Confederation of Medical Mycology (ECMM) Excellence Center, Centre National de Référence Aspergilloses Chroniques, Rennes Teaching Hospital, F-35000 Rennes, France
| | - Juliette Guitard
- Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, Paris, France
| | - Lilia Hasseine
- Parasitologie - Mycologie, Hôpital de l'Archet, CHU Nice, Nice, Provence-Alpes-Côte d'Azur, France
| | - Antoine Huguenin
- Université de Reims Champagne Ardenne, ESCAPE EA7510, Laboratoire de Parasitologie-Mycologie, Pôle de Biologie Pathologie, CHU de Reims, Rue du Général Koening, Reims, France
| | - Solène Le Gal
- CHU de Brest, Laboratoire de Parasitologie-Mycologie, Univ Brest, Univ Angers, Infections Respiratoires Fongiques, F-29200, Brest, France
| | - Valérie Letscher-Bru
- Laboratoire de Parasitologie et Mycologie Médicale, Les Hôpitaux Universitaires de Strasbourg, Institut de Parasitologie et Pathologie Tropicale, UR7292 Dynamique des interactions hôte pathogène, Fédération de Médecine Translationnelle, Université de Strasbourg, Strasbourg, France
| | - Caroline Mahinc
- Centre Hospitalier Universitaire de Saint Etienne, Service de Parasitologie Mycologie, Saint Etienne, France
| | - Florent Morio
- Nantes Université, CHU Nantes, Cibles et Médicaments des Infections et de l'Immunité, UR1155, Nantes, France
| | - Muriel Nicolas
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Guadeloupe, Pointe-à-Pitre, Guadeloupe, France
| | - Philippe Poirier
- Université Clermont Auvergne, Inserm, 3IHP, Centre Hospitalier Universitaire Clermont-Ferrand, Service de Parasitologie-Mycologie, Clermont-Ferrand, France
| | - Stéphane Ranque
- Aix-Marseille Université, IHU Méditerranée Infection, AP-HM, IRD, SSA, VITROME, 13005 Marseille, France
| | | | - Célia Rouges
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Anne-Laure Roux
- Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France; AP-HP, GHU Paris Saclay, Hôpital Ambroise Paré, Microbiology Department, Boulogne-Billancourt, France
| | - Milène Sasso
- Laboratoire de Parasitologie-Mycologie, CHU Nîmes & Université de Montpellier, CNRS, IRD, MiVEGEC, Montpellier, France
| | - Alexandre Alanio
- Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France; Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France
| | - Olivier Lortholary
- Université Paris Cité, Department of Infectious Diseases and Tropical Medicine, Necker - Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), IHU Imagine, 75014 Paris, France; Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France
| | - Fanny Lanternier
- Université Paris Cité, Department of Infectious Diseases and Tropical Medicine, Necker - Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), IHU Imagine, 75014 Paris, France; Mycology Department, Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Mycology Translational Research Group, France
| |
Collapse
|
2
|
Galmiche S, Thoreau B, Bretagne S, Alanio A, Paugam A, Letscher-Bru V, Cassaing S, Gangneux JP, Guegan H, Favennec L, Minoza A, Morio F, Bonhomme J, Desoubeaux G, Eloy O, Hasseine L, Sasso M, Millon L, Bellanger AP, Poirier P, Moniot M, Chouaki T, Huguenin A, Dalle F, Bouteille B, Nicolas M, Desbois-Nogard N, Bougnoux ME, Danion F, Poindron V, Néel A, Boukris-Sitbon K, Lanternier F, Terrier B. Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network. RMD Open 2023; 9:e003281. [PMID: 37558492 PMCID: PMC10414070 DOI: 10.1136/rmdopen-2023-003281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Accepted: 07/28/2023] [Indexed: 08/11/2023] Open
Abstract
OBJECTIVES We aimed to describe patients with autoimmune diseases (AID) developing invasive fungal disease (IFD) and identify factors associated with short-term mortality. METHODS We analysed cases of IFD associated with AID from the surveillance network of invasive fungal diseases (Réseau de surveillance des infections fongiques invasives, RESSIF) registry of the French national reference centre for invasive mycoses. We studied association of AID-specific treatments with 30-day mortality. We analysed total lymphocyte and CD4-T cell counts in patients with Pneumocystis jirovecii pneumonia (PCP). RESULTS From 2012 to 2018, 549 individuals with IFD and AID were included, mainly with PCP (n=227, 41.3%), fungemia (n=167, 30.4%) and invasive aspergillosis (n=84, 15.5%). Rheumatoid arthritis (RA) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) were the most frequent AID in PCP (n=55 and 25, respectively) and invasive aspergillosis (n=15 and 10, respectively), inflammatory bowel diseases (IBDs) were predominant in fungemia (n=36). At IFD diagnosis, 365 (66.5%) patients received glucocorticoids (GCs), 285 (51.9%) immunosuppressants, 42 (7.7%) tumor necrosis factor (TNF)-α blockers, 75 (13.7%) other biologics. Mortality at 30 days was 28.1% (143/508). Fungemia and high-dose GCs were independently associated with higher 30-day mortality. In PCP patients, lymphopenia <1500/mm3 was frequent (132/179, 73.7%) even if CD4+T cell count exceeded 200/mm3 in 56/78 patients (71.8%) (median 472.5/mm3, IQR 160-858). CONCLUSION IFD associated with AID occurs primarily in RA, AAV and IBD, especially when treated with GCs and immunosuppressants. Mortality is high, especially for patients on high-dose GCs. Lymphopenia may help identify risk of PCP, but normal CD4+T cell count does not rule out the risk. Further studies are needed to assess the individual risk factors for IFD.
Collapse
Affiliation(s)
- Simon Galmiche
- Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, Île-de-France, France
- Ecole doctorale Pierre Louis de santé publique, Sorbonne Université, Paris, France
| | - Benjamin Thoreau
- National Referral Center for Rare Systemic Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP-HP, Université Paris Cité, Paris, Île-de-France, France
- INSERM U1016, Cochin Institute, Paris, Université Paris Cité, CNRS UMR 8104, Paris, Île-de-France, France
| | - Stéphane Bretagne
- Parasitologie - Mycologie, Hôpital St Louis, APHP, Paris, Île-de-France, France
- Institut Pasteur, Université Paris Cité, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, Île-de-France, France
| | - Alexandre Alanio
- Parasitologie - Mycologie, Hôpital St Louis, APHP, Paris, Île-de-France, France
- Institut Pasteur, Université Paris Cité, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, Île-de-France, France
| | - André Paugam
- Parasitologie - Mycologie, Université Paris Cité, Cochin Hospital, APHP, Paris, Île-de-France, France
| | - Valérie Letscher-Bru
- Laboratoire de Parasitologie et Mycologie Médicale, Les Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- Institut de Parasitologie et Pathologie Tropicale, UR7292 Dynamique des interactions hôte pathogène, Fédération de Médecine Translationnelle, Université de Strasbourg, Strasbourg, France
| | - Sophie Cassaing
- Parasitologie - Mycologie, Université de Toulouse, CHU Toulouse, Toulouse, Occitanie, France
- PharmaDev, Faculté de Pharmacie, Université de Toulouse, UPS, IRD, Toulouse, Occitanie, France
| | - Jean-Pierre Gangneux
- Université de Rennes, CHU, INSERM, Irset: Institut de Recherche en Santé, Environnement et Travail, UMR_S 1085, Rennes, France
| | - Hélène Guegan
- Université de Rennes, CHU, INSERM, Irset: Institut de Recherche en Santé, Environnement et Travail, UMR_S 1085, Rennes, France
| | - Loïc Favennec
- French National Cryptosporidiosis Reference Center, CHU de Rouen, Rouen, Normandie, France
- EA 7510, UFR Santé, University of Rouen Normandy, Normandy University, Rouen, France
| | - Alida Minoza
- Faculté de Médecine et Pharmacie, Université de Poitiers, Poitiers, Nouvelle-Aquitaine, France
- Département des agents anti-infectieux, Service de Mycologie-Parasitologie, CHU Poitiers, Poitiers, France
| | - Florent Morio
- Parasitologie - Mycologie, CHU Nantes, Nantes, Pays de la Loire, France
- UR 1155 IICiMed, Institut de Recherche en Santé 2, Université de Nantes, Nantes, Pays de la Loire, France
| | - Julie Bonhomme
- Microbiologie, CHU de Caen, ToxEMAC-ABTE Unicaen, Caen, Normandie, France
| | - Guillaume Desoubeaux
- Centre d'Étude des Pathologies Respiratoires - Inserm UMR1100, Université de Tours, Tours, France
- Parasitologie - Mycologie - Médecine tropicale, CHU de Tours, Tours, Centre-Val de Loire, France
| | - Odile Eloy
- Microbiologie, CH Versailles, Le Chesnay, Île-de-France, France
| | - Lilia Hasseine
- Parasitologie - Mycologie, hôpital de l'Archet, CHU Nice, Nice, Provence-Alpes-Côte d'Azur, France
| | - Milène Sasso
- Laboratoire de Parasitologie - Mycologie, CHU Nîmes, Université de Montpellier, CNRS, IRD, MiVEGEC, Nimes, Occitanie, France
| | - Laurence Millon
- Laboratoire de Parasitologie - Mycologie, CHU de Besançon, Besançon, Bourgogne-Franche-Comté, France
- UMR 6249 CNRS Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, Bourgogne - Franche-Comté, France
| | - Anne-Pauline Bellanger
- Laboratoire de Parasitologie - Mycologie, CHU de Besançon, Besançon, Bourgogne-Franche-Comté, France
| | - Philippe Poirier
- Parasitologie - Mycologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
- Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), UMR Inserm/Université Clermont Auvergne U1071, USC INRA 2018, Clermont-Ferrand, Auvergne-Rhône-Alpes, France
| | - Maxime Moniot
- Parasitologie - Mycologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Taieb Chouaki
- Mycologie - parasitologie, CHU Amiens-Picardie, Amiens, Hauts-de-France, France
| | - Antoine Huguenin
- Parasitologie - Mycologie, hôpital Maison-Blanche, CHU de Reims, Reims, France
| | - Frédéric Dalle
- Parasitologie - Mycologie, Plateforme de Biologie Hospitalo-Universitaire Gérard Mack, Dijon, Bourgogne-Franche-Comté, France
- UMR PAM Univ Bourgogne Franche-Comté - AgroSup Dijon - Equipe Vin, Aliment, Microbiologie, Stress, Université Bourgogne Franche-Comté, Dijon, Bourgogne-Franche-Comté, France
| | - Bernard Bouteille
- Parasitologie - Mycologie, Centre de Biologie et de Recherche en Santé, CHU Limoges, Limoges, Nouvelle-Aquitaine, France
| | - Muriel Nicolas
- Mycologie - Parasitologie, Centre Hospitalier Universitaire Pointe-à-Pitre Abymes, Pointe-à-Pitre, Guadeloupe
| | | | - Marie-Elisabeth Bougnoux
- Laboratoire de Parasitologie - Mycologie, Service de Microbiologie, Necker-Enfants Malades University Hospital, APHP, Paris, Île-de-France, France
- Institut Pasteur, Université Paris Cité, Unité Biologie et Pathogénicité Fongiques, Département Mycologie, Paris, Île-de-France, France
| | - François Danion
- Maladies infectieuses et tropicales, Les Hôpitaux Universitaires de Strasbourg, Strasbourg, Grand Est, France
- Laboratoire d'Immuno-rhumatologie moléculaire UMR_S 1109, INSERM, Strasbourg, Grand Est, France
| | - Vincent Poindron
- Service d'Immunologie clinique, Hopitaux universitaires de Strasbourg, Strasbourg, France
| | - Antoine Néel
- CRTI UMR 1064, INSERM, Université de Nantes, Nantes, France
- Service de Médecine interne, CHU Nantes, Nantes, Pays de la Loire, France
| | - Karine Boukris-Sitbon
- Institut Pasteur, Université Paris Cité, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, Île-de-France, France
| | - Fanny Lanternier
- Institut Pasteur, Université Paris Cité, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, Île-de-France, France
- Infectious Diseases Unit, Necker-Enfants Malades University Hospital, AP-HP, Paris, France
| | - Benjamin Terrier
- National Referral Center for Rare Systemic Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP-HP, Université Paris Cité, Paris, Île-de-France, France
- Université Paris Cité, U970, PARCC, INSERM, Paris, Île-de-France, France
| |
Collapse
|
3
|
Françoise U, Desnos-Ollivier M, Le Govic Y, Sitbon K, Valentino R, Peugny S, Chouaki T, Mazars E, Paugam A, Nicolas M, Desbois-Nogard N, Lortholary O. Candida haemulonii complex, an emerging threat from tropical regions? PLoS Negl Trop Dis 2023; 17:e0011453. [PMID: 37523406 PMCID: PMC10437918 DOI: 10.1371/journal.pntd.0011453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 08/18/2023] [Accepted: 06/09/2023] [Indexed: 08/02/2023] Open
Abstract
BACKGROUND Candida haemulonii complex-related species are pathogenic yeasts closely related to Candida auris with intrinsic antifungal resistance, but few epidemiological data are available. METHODOLOGY/PRINCIPAL FINDINGS We analyzed clinical and demographic characteristics of patients with fungemia due to C. haemulonii complex and related species (C. pseudohaemulonii, C. vulturna) reported in France during 2002-2021, and compared them to data of C. parapsilosis fungemia, as they all can be commensal of the skin. We also conducted a study on adult inpatients and outpatients colonized by C. haemulonii complex, managed at the University Hospital of Martinique during 2014-2020. Finally, we performed a literature review of fungemia due to C. haemulonii complex and related species reported in Medline (1962-2022). In total, we identified 28 fungemia due to C. haemulonii complex in France. These episodes were frequently associated with bacterial infection (38%) and high mortality rate (44%), and differed from C. parapsilosis fungemia by their tropical origin, mainly from Caribbean and Latin America. All isolates showed decreased in vitro susceptibility to amphotericin B and fluconazole. In Martinique, we found that skin colonization was frequent in the community population, while colonization was strongly associated with the presence of foreign devices in ICU patients. The literature review identified 274 fungemia episodes, of which 56 were individually described. As in our national series, published cases originated mainly from tropical regions and exhibited high crude mortality. CONCLUSIONS/SIGNIFICANCE Multidrug-resistant C. haemulonii complex-related species are responsible for fungemia and colonization in community and hospital settings, especially in tropical regions, warranting closer epidemiological surveillance to prevent a potential C. auris-like threat.
Collapse
Affiliation(s)
- Ugo Françoise
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Marie Desnos-Ollivier
- Centre National de Référence des Mycoses invasives et Antifongiques, Département de Mycologie, Institut Pasteur, Université de Paris Cité, Paris, France
| | - Yohann Le Govic
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Karine Sitbon
- Centre National de Référence des Mycoses invasives et Antifongiques, Département de Mycologie, Institut Pasteur, Université de Paris Cité, Paris, France
| | - Ruddy Valentino
- Service de réanimation, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Sandrine Peugny
- Unité de Maladies Infectieuses et Tropicales, Centre Hospitalier de Cayenne, Cayenne, Guyane Française, France
| | - Taieb Chouaki
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
| | - Edith Mazars
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier de Valenciennes, Valenciennes, France
| | - André Paugam
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Muriel Nicolas
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Guadeloupe, Pointe-à-Pitre, Guadeloupe, France
| | - Nicole Desbois-Nogard
- Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Olivier Lortholary
- Centre National de Référence des Mycoses invasives et Antifongiques, Département de Mycologie, Institut Pasteur, Université de Paris Cité, Paris, France
- Institut Imagine, Paris, France
- Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France
| | | |
Collapse
|
4
|
Camous L, Surel A, Kallel H, Nicolas M, Martino F, Valette M, Demoule A, Pommier JD. Factors related to mortality in critically ill histoplasmosis: a multicenter retrospective study in Guadeloupe and French Guyana. Ann Intensive Care 2023; 13:30. [PMID: 37085583 PMCID: PMC10121956 DOI: 10.1186/s13613-023-01128-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Accepted: 04/13/2023] [Indexed: 04/23/2023] Open
Abstract
PURPOSE To describe clinical and biological features and the outcomes of patients admitted for histoplasmosis in two intensive care units (ICU) in French Guyana and in the French West Indies (Guadeloupe). METHODS All patients admitted to these two ICUs for culture-proven histoplasmosis between January 2014 to August 2022 were included in the study. Using univariate and multivariate analysis, we assessed risk factors at ICU admission that were associated with death. RESULTS Forty patients were included (65% men). Median age was 56 years and simplified acute physiologic score (SAPS) II was 65. HIV was found in 58%, another immunodeficiency was identified in 28%, and no underlying immunodeficiency could be identified in 14% of patients. Within the first 24 h of ICU admission, 85% of patients had acute respiratory failure, 78% had shock, 30% had coma, and 48% had hemophagocytic lymphohistiocytosis. Mechanical ventilation was instituted in 78% of patients and renal replacement therapy in 55%. The 30-day mortality was 53%. By multivariate analysis, factors independently associated with 30-day mortality were SOFA score (odds ratio [OR] 1.5, 95% confidence interval [CI] [1.1-2.1]), time between symptom onset and treatment per day (OR 1.1, 95% CI 1.0-1.1), and hemophagocytic lymphohistiocytosis (OR 6.4, 95% CI 1.1-47.5). CONCLUSION Histoplasmosis requiring ICU admission is a protean disease with multiple and severe organ involvement. Immunodeficiency is found in most patients. The prognosis remains severe despite appropriate treatment and is worsened by late treatment initiation.
Collapse
Affiliation(s)
- Laurent Camous
- Intensive Care Unit, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France.
- Réanimation médicale et chirurgicale-CHU de Guadeloupe, 97139, Les Abyme, France.
| | - Arthur Surel
- Intensive Care Unit, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France
| | - Hatem Kallel
- Intensive Care Unit, Cayenne Hospital, French Guyana, France
| | - Muriel Nicolas
- Mycology Department, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France
| | - Frederic Martino
- Intensive Care Unit, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France
- Université de Paris and Université des Antilles, INSERM, BIGR, 75015, Paris, France
| | - Marc Valette
- Intensive Care Unit, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France
| | - Alexandre Demoule
- UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, INSERM, 75005, Paris, France
- Service de Médecine Intensive et Réanimation (Département R3S), AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, 75013, Paris, France
| | - Jean-David Pommier
- Intensive Care Unit, Guadeloupe Teaching Hospital, Antilles-Guyane University, Chemin de Chauvel, Les Abymes, France
- Institut Pasteur de Guadeloupe, Morne Jolivière, 97139, Les Abymes, France
| |
Collapse
|
5
|
Rachas A, Gastaldi-Ménager C, Denis P, Barthélémy P, Constantinou P, Drouin J, Lastier D, Lesuffleur T, Mette C, Nicolas M, Pestel L, Rivière S, Tajahmady A, Gissot C, Fagot-Campagna A. The Economic Burden of Disease in France From the National Health Insurance Perspective: The Healthcare Expenditures and Conditions Mapping Used to Prepare the French Social Security Funding Act and the Public Health Act. Med Care 2022; 60:655-664. [PMID: 35880776 PMCID: PMC9365254 DOI: 10.1097/mlr.0000000000001745] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN Annual cross-sectional study (2015-2019) based on the French national health database. SUBJECTS National health insurance beneficiaries (97% of the French residents). MEASURES All individual health care expenditures reimbursed by the national health insurance were attributed to 58 health conditions (treated diseases, chronic treatments, and episodes of care) identified by using algorithms based on available medical information (diagnosis coded during hospital stays, long-term diseases, and specific drugs). RESULTS In 2019, €167.0 billion were reimbursed to 66.3 million people (52% women, median age: 42 y). The most prevalent treated diseases were diabetes (6.0%), chronic respiratory diseases (5.5%), and coronary diseases (3.2%). Coronary diseases accounted for 4.6% of expenditures, neurotic and mood disorders 3.7%, psychotic disorders 2.8%, and breast cancer 2.1%. Between 2015 and 2019, the expenditures increased primarily for diabetes (+€906 million) and neurotic and mood disorders (+€861 million) due to the growing number of patients. "Active lung cancer" (+€797 million) represented the highest relative increase (+54%) due to expenditures for the expensive drugs and medical devices delivered at hospital. CONCLUSIONS These results have provided policy-makers, evaluators, and public health specialists with key insights into identifying health priorities and a better understanding of trends in health care expenditures in France.
Collapse
Affiliation(s)
- Antoine Rachas
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Christelle Gastaldi-Ménager
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Pierre Denis
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Pauline Barthélémy
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Panayotis Constantinou
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Jérôme Drouin
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Dimitri Lastier
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Thomas Lesuffleur
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Corinne Mette
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Muriel Nicolas
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Laurence Pestel
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Sébastien Rivière
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Ayden Tajahmady
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Claude Gissot
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| | - Anne Fagot-Campagna
- Direction de la stratégie, des études et des statistiques, Caisse Nationale d’Assurance Maladie, Paris, France
| |
Collapse
|
6
|
Nunez - Calonge R, Nicolas M, Abellan F, Armijo O, Baccino G, Feito L, Fuente ADL, Roca M, Santalo J. P-344 Number of cryopreserved embryos stored in Spain depending on their destination. Hum Reprod 2022. [DOI: 10.1093/humrep/deac106.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
How many frozen embryos are stored in Spain destined for donation to other couples, research, destruction, own use or abandoned?
Summary answer
In Spain, 5% of frozen embryos are destined for donation to other patients, 17% are fated for research, 17,7% for destruction and 12% are abandoned
What is known already
According to the latest data from the Spanish Fertility Society (SEF) registry, the total number of embryos stored in Spain in 2019, was 668.082. Clinics ask patients to specify their preferences for the embryo’s destinations such as: save the embryos for the future, donation to other patients, research, or discarding the embryos. Embryos were considered abandoned when a patient with frozen embryo/s stored failed to contact the clinic for > 2 years and the patient could not be located. However, it is not known how many embryos are assigned to each destination, neither in Spain nor in any other country
Study design, size, duration
Reflecting concern about the accumulation of frozen embryos in banks, SEF convened a focus group with key figures in ethics, law, and reproductive medicine to identify possible solutions. The first step was to carry out a questionnaire to all the reproduction centres in Spain to know the number of frozen embryos stored and their destinations. A total of 242 IVF units were contacted through SEF newsletter and participants answered between April and July 2021
Participants/materials, setting, methods
Public and private IVF clinics which had cryopreserved embryos were sent questionnaires with requests regarding the number of frozen embryos in each destination: keeping for patients, donated to other patients who met donation criteria (same as for gamete donors) and who did not meet criteria, research to a specific project and without a project, destined for destruction that met the criteria established by law, and that did not meet criteria, and number of embryos abandoned.
Main results and the role of chance
A total of 71 filled-in questionnaires from 242 IVF clinics were obtained. The response rate to the questionnaire was 29%. Of the respondents, a total of 376.445 stored embryos were reported. 46% of the total cryopreserved embryos were kept for later use by patients. 3.7% were donated to other couples but did not meet the criteria for donation: obtained from women over 35 years, or lack of any required test. 1.4% of the embryos were donated fulfilling the criteria for donation to other patients. 17% of the embryos were donated for research, but less than 1% had an assigned project. 17.7% of the frozen embryos were destined for termination of their conservation, and 1.4% of them did not meet the criteria established by law. A total of 46.046 embryos could be considered abandoned since the patients could not be contacted after more than two years of storage. This represents 12.2% of embryos without a defined destination.
Limitations, reasons for caution
The main limitation of this study is the low response rate, since out of 242 centres, which obligatory sent their data to the National Registry in 2019, only 71 centres answered. This could be due to the lack of data from some reproduction units
Wider implications of the findings
It is not known precisely how many frozen embryos have been abandoned in Spain, or what are their other destinations. Clinics are not required by authorities to report these number but to have concrete data on the frozen embryos is crucial to solve the problem of embryo accumulation in banks.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- R Nunez - Calonge
- Scientific advisor UR International Group, Reproduction Unit , Madrid, Spain
| | - M Nicolas
- IVIRMA, Reproduction , Murcia, Spain
| | - F Abellan
- Sociedad Española de Fertilidad , Legal, Madrid, Spain
| | - O Armijo
- Hospital Universitario La Paz, Reproduction Unit , Madrid, Spain
| | - G Baccino
- Psychology Group of the European Society for Human Reproduction and Embryology, Coordinator of Psychology Group , Madrid, Spain
| | - L Feito
- Faculty of Medicine- Complutense University, Public Health & Maternal and Child Health , Madrid, Spain
| | - A. de la Fuente
- European Institute of Fertilidad , Reproduction, Madrid, Spain
| | - M Roca
- Hospital Quirón, Psychology , Barcelona, Spain
| | - J Santalo
- Universidad Autonoma, Cell Biology , Barcelona, Spain
| |
Collapse
|
7
|
Claret PG, Lefebvre M, Nicolas M, Bientz M, Groussac M, Courté M. Actualités en médecine d’urgence. Ann Fr Med Urgence 2022. [DOI: 10.3166/afmu-2021-0366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
8
|
Chaptal M, Gallois JC, Étienne N, Mathon G, Nicolas M, Cadelis G. [Pulmonary histoplasmosis in an immunocompetent patient]. Rev Mal Respir 2020; 37:422-426. [PMID: 32409000 DOI: 10.1016/j.rmr.2020.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Accepted: 03/25/2020] [Indexed: 11/27/2022]
Abstract
INTRODUCTION Acute pulmonary histoplasmosis (APH) is rare in an immunocompetent patient. We report a case of APH diagnosed by culture of broncho-alveolar lavage (BAL) in a patient presenting a pseudo-tumoral form with nodules progressing to cavitation. OBSERVATION A 41 year-old male smoker was hospitalized with a persistent fever, dry cough and dyspnoea on exertion. The first CT scan showed a reticulo-nodular interstitial infiltrate with lymphadenopathy that progressed rapidly to multiple pulmonary nodules with central cavitation. Bronchial endoscopy, with BAL culture, provided the diagnosis of Histoplasma capsulatum, variety capsulatum. The infection may have occurred during work in a hangar in Guadeloupe that was scattered with bats' guano. After two months of treatment by itraconazole, the patient's condition improved clinically and radiologically with reduction of the nodules and their cavitation. CONCLUSION This case presents an immunocompetent patient with pulmonary histoplasmosis and multiple, radiologically atypical, nodules. The diagnosis was established by BAL culture.
Collapse
Affiliation(s)
- M Chaptal
- Service de pneumologie CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France.
| | - J-C Gallois
- Service de pneumologie CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France
| | - N Étienne
- Service de pneumologie CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France
| | - G Mathon
- Service de radiologie, CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France
| | - M Nicolas
- Laboratoire de mycologie-parasitologie, CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France
| | - G Cadelis
- Service de pneumologie CHU de Pointe-à-pitre/Abymes, route de chauvel, BP 465, 97159 Pointe-à-Pitre, Guadeloupe, France
| |
Collapse
|
9
|
Merino L, Edberg U, Fuchs G, Åman P, Corbari G, Dahlberg L, Da-Riz V, Eerola S, Gerard R, Grancher D, Jensen S, Kangro A, Kjolby A, Lundberg L, Marin M, Meland S, Muriel B, Nicolas M, Ravn T, Tuhkanen M, Vartiala T, Zieprath G. Liquid Chromatographic Determination of Residual Nitrite/Nitrate in Foods: NMKL Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/83.2.365] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Nitrite and nitrate are used as additives in the food industry to provide color and taste and to control undesirable gas and flavor production by anaerobic bacteria by virtue of their antimicrobial properties. The analytical method that has been widely used to determine nitrite and nitrate involves the use of toxic cadmium. In response to a request from the Nordic Committee on Food Analysis, a study was performed to obtain an alternative chromatographic method to determine residual nitrite and nitrate in meat products. The study was done in 3 stages: (1) comparative evaluation of the performance of 3 liquid chromatographic methods, (2) internal validation of the selected ion chromatographic method, and (3) a collaborative study in which 17 laboratories from European countries participated. Furthermore, the applicability of the method to matrixes other than meat and meat products was demonstrated. The results of the collaborative study show that the European Prestandard prENV 12014-4 is well suited for the determination of nitrite and nitrate in different foods (e.g., meat products, vegetables, baby food, and cheese). The limits of detection for nitrite and nitrate ions are 1 and 10 mg/kg, respectively. Recoveries of residual nitrite/nitrate ranged from 96 to 108%. Repeatability and reproducibility were satisfactory.
Collapse
Affiliation(s)
- Leonardo Merino
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Ulla Edberg
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Georg Fuchs
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Per Åman
- Swedish University of Agricultural Sciences, Box 7051, S-750 07 Uppsala, Sweden
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Denis P, Aguadé A, Lesuffleur T, Pestel L, Nicolas M, Rachas A, Gastaldi-Menager C. Economic burden of diabetes in France between 2012 and 2017 based on French national claim database. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz187.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The aim of this study is to assess the economic burden of diabetes in France based on a top-down allocation of health care expenditure, and to analyze structure and trends of expenditure between 2012 and 2017.
Methods
Using information about 57 millions of individuals from the general scheme insurance database (87% of the French population), we applied algorithms based on ICD-10 diagnoses, long-term diseases, and specific treatments. All reimbursed expenditure (drugs, medical visit and other ambulatory care, hospitalization, disability/sickness benefits) were extracted for each individual. A top-down method was used to allocate expenditure to diabetes. To analyze trends, we applied the same methodology from 2012 through 2017.
Results
In 2016 (results for 2017 will be available for the conference), among the 137 billion euros reimbursed, 6.8 billion (5%) were attributed to diabetes and 3.2 million people were concerned (5.5% of the population). Drugs represented the main expenditure item (31% of the average annual expenditure per patient related to diabetes), followed by nursing (18%) and medical devices (17.5%). From 2012 to 2016, the number of people with diabetes increased by 11.4% (+322 700) with an increase by 2.7%/year, the expenditure attributed to diabetes increased by 2.3%/year. The average expenditure per patient in 2016 was about €2150, slightly decreasing from 2012, mainly due to price controls on antidiabetics drugs which permits to limit expenditure growth.
Conclusions
Our study shows the high economic burden of diabetes in France with a detailed analysis of expenditures and their main drivers. With the arrival of innovation and predicted increase of the number of patients partly related to ageing process, control of expenditure must be a priority. The developed tool will help decision makers to monitor the burden of diabetes but also to provide stakeholders with a better understanding of trends and regulating actions.
Key messages
Diabetes represents a high proportion of healthcare expenditure in France. With the arrival of innovation and predicted increase of the number of patients partly related to ageing process, control of expenditure must be a priority.
Collapse
|
11
|
Nicolas M, Pestel L, Rivière S, Rachas A, Gastaldi-Menager C. Economic burden of cardiovascular diseases from 2012 to 2017 based on French national claim database. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz187.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The purpose of this study was to assess the economic burden of cardiovascular diseases (CVDs) in France by analysing the structure and the growth of expenditure attributed to these diseases between 2012 and 2017.
Methods
For each year, 11 CVDs were identified from SNDS data using algorithms based on long-term disease registry and hospitalization diagnoses, applied to the population of national health insurance general scheme beneficiaries. The individuals’ expenditure (26 different items) reimbursed for hospitalisations, ambulatory care and cash payments were included. A top-down method was used to attribute expenditure to each considered groups of diseases based on the average expenditure by disease calculated for individuals with only one disease. To analyse trends, we applied the same methodology from 2012 to 2017.
Results
In 2017, of the €140.1 billion reimbursed, €14.0 billion (10.0%) were attributed to the care of 4.0 million people with a CVD (7.0% of the population). Short-stay hospitalisations accounted for 33% of this total expenditure. This proportion was higher for acute CVD (coronary syndrome: 64%, stroke: 56%, heart failure: 65%, pulmonary embolism: 69%) but also for valvular heart disease (50.0%). Medications represented almost 13% of the expenditure attributed to all CVDs, and up to 25% for chronic coronary heart disease. Disability pension essentially concerned sequelae of stroke (12% of the expenditure attributed to this disease). Between 2012 and 2017, the total expenditure attributed to CVDs increased by 3.3% per year, mainly due to the annual mean increase of the number of patients over the period (+3.1%).
Conclusions
These results demonstrate the high economic burden of CVDs in France with a detailed analysis of expenditures and their main drivers. The developed tool will help decision makers to monitor the burden of these diseases but also to provide stake holders with a better understanding of trends and regulating actions.
Key messages
Economic burden of CVD in France is high: 10% of healthcare expenditure. Implementation of public health policy to prevent CVD and control risk factors must be a priority.
Collapse
Affiliation(s)
- M Nicolas
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - L Pestel
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - S Rivière
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - A Rachas
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - C Gastaldi-Menager
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| |
Collapse
|
12
|
Verboux D, Pestel L, Nicolas M, Lesuffleur T, Rachas A, Gastaldi-Menager C. Economic burden of cancer from 2012 to 2017 based on the French national claim database (SNDS). Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz185.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The aim of this study is to assess the economic burden of active cancer in France and to analyze structure and trends of expenditure between 2012 and 2017.
Methods
Using information about 57 millions of individuals from the general scheme insurance database (86% of the French population) and applying 5 specifically developed medical algorithms (for lung, colon, breast, prostate and other cancers), we identified all people with active cancer. All reimbursed expenditure (hospitalization, ambulatory care, disability/sickness benefits) were extracted for each individual. To analyze trends, we applied the same methodology from 2012 through 2017.
Results
In 2016 (results for 2017 will be available for the conference), among the 137 billion euros reimbursed by the general assurance scheme, 13 billion (10%) were related to active cancer and 1.2 million people were concerned (2% of the population). About 2.3 billion euros (2%) were related to breast cancer (189,000 people), 1.4 billion euros (1%) for colon cancer (123,000 people), 1.4 billion euros (1%) for lung cancer (77,000 people) and 1 billion (0.8%) for prostate cancer (167,000 people). Hospitalizations represented the main expenditure for colon (71%), lung (61%) and breast cancer (56%). Concerning prostate cancer, hospitalizations stood for 36% while ambulatory care represented 62%. From 2012 to 2016, the expenditure related to active cancer increase by 4.4%/year due to both an increase in patients and in the average annual cost per patient (both +2.2% per year). Focusing on breast cancer, average expenditure increased by 3.2% per year from 10,700€ per year per patient to 12,200€ per year per patient.
Conclusions
Our study demonstrates the high economic burden of active cancer in France with a detailed analysis of expenditures. The developed tool will help to monitor the burden of these diseases and to implement public health policies.
Key messages
Active cancers account for a significant proportion of healthcare expenditure in France. Knowing this weight allows designing and implementing public policies adapted to the situation.
Collapse
Affiliation(s)
- D Verboux
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - L Pestel
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - M Nicolas
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - T Lesuffleur
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - A Rachas
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| | - C Gastaldi-Menager
- Department of Studies on Diseases and Patients, Caisse Nationale d’Assurance Maladie, Paris, France
| |
Collapse
|
13
|
Vacher P, Filaire E, Mourot L, Nicolas M. Stress and recovery in sports: Effects on heart rate variability, cortisol, and subjective experience. Int J Psychophysiol 2019; 143:25-35. [DOI: 10.1016/j.ijpsycho.2019.06.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Revised: 06/18/2019] [Accepted: 06/18/2019] [Indexed: 10/26/2022]
|
14
|
Diallo K, Lefevre B, Cadelis G, Gallois JC, Gandon F, Nicolas M, Hoen B. A case report of fungemia due to Kodamaea ohmeri. BMC Infect Dis 2019; 19:570. [PMID: 31262263 PMCID: PMC6604277 DOI: 10.1186/s12879-019-4208-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Accepted: 06/19/2019] [Indexed: 11/17/2022] Open
Abstract
Background Kodamaea ohmeri is a yeast is frequently mistaken for Candida, which belongs to the same family. This micro-organism has been reported to cause life-threatening infections in humans. Case presentation A 81-year-old woman developed a severe fungemic pulmonary infection due to Kodamaea ohmeri that was identified from bronchoalveolar fluid and blood cultures, which is unusual in immunocompetent patients. Because K. ohmeri was first wrongly identified as Candida albicans, the patient inadequately received caspofungin, which was clinically ineffective, especially as the strain was resistant to echinocandins. Clinical cure was obtained after treatment was switched to voriconazole. Conclusions An increasing number of serious infections due to K. ohmeri has been reported in the literature, but the correct identification of this micro-organism remains difficult.
Collapse
Affiliation(s)
- K Diallo
- Department of Infective and Tropical Diseases, Dermatology and Internal Medicine, University Hospital of Pointe à Pitre, Pointe à Pitre, France.
| | - B Lefevre
- Department of Infective and Tropical Diseases, Dermatology and Internal Medicine, University Hospital of Pointe à Pitre, Pointe à Pitre, France
| | - G Cadelis
- Lung diseases unit, University Hospital of Pointe à Pitre, Pointe à Pitre, France
| | - J C Gallois
- Lung diseases unit, University Hospital of Pointe à Pitre, Pointe à Pitre, France
| | - F Gandon
- Laboratory of bacteriology, parasitology and mycology, University Hospital of Pointe à Pitre, Pointe à Pitre, France
| | - M Nicolas
- Laboratory of bacteriology, parasitology and mycology, University Hospital of Pointe à Pitre, Pointe à Pitre, France
| | - B Hoen
- Department of Infective and Tropical Diseases, Dermatology and Internal Medicine, University Hospital of Pointe à Pitre, Pointe à Pitre, France.,INSERM Clinical Investigation Center 1424, University Hospital of Pointe à Pitre, Pointe à Pitre, France.,University of the French West Indies and French Guyana, Medical School Hyacinthe Bastaraud, EA 4537, Pointe à Pitre, France
| |
Collapse
|
15
|
Diallo K, Nicolas M. A 26-year-old man with a leg ulceration. Presse Med 2019; 48:466-467. [DOI: 10.1016/j.lpm.2019.02.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2018] [Revised: 12/03/2018] [Accepted: 02/13/2019] [Indexed: 11/17/2022] Open
|
16
|
Nicolas M, Droupy S, Costa P. Efficacité des ballons Pro-ACT™ dans le traitement de seconde ligne de l’incontinence urinaire d’effort post-prostatectomie après échec des bandelettes sous-urétrales. Prog Urol 2019; 29:36-44. [DOI: 10.1016/j.purol.2018.09.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2016] [Revised: 05/28/2018] [Accepted: 09/15/2018] [Indexed: 10/28/2022]
|
17
|
Cura P, Guinard E, Florian D, Lamant L, Malloizel J, Bulai Livideanu C, Chaput B, Paul C, Nicolas M. Une association d’ulcères extensifs et d’une sclérose cutanée révélatrice de siliconomes. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
18
|
Devos C, Nicolas M, Ruffion A, Terrier J. Indications de la réalisation d’un lambeau de Martius, résultats et complications postopératoires. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
19
|
Canha A, Mollá M, Fernandez L, Nicolas M, Trabalon M, Landeras J, Coy P, Chavarro J. Alcohol use and tobacco smoking in relation to ovarian response among egg donors. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Vacher P, Martinent G, Mourot L, Nicolas M. Elite swimmers’ internal markers trajectories in ecological training conditions. Scand J Med Sci Sports 2018; 28:1866-1877. [DOI: 10.1111/sms.13200] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/13/2018] [Indexed: 12/30/2022]
Affiliation(s)
- P. Vacher
- EuroMov; University of Montpellier; Montpellier France
- Laboratory Psy-DREPI (EA 7458); University of Bourgogne Franche-Comté; Dijon France
| | - G. Martinent
- Laboratory L-VIS (EA 7428); University of Claude Bernard Lyon 1; Univ-Lyon France
| | - L. Mourot
- EA 3920 and Exercise, Performance, Health and Innovation Platform; University of Bourgogne; Franche-Comté France
- Tomsk Polytechnic University; Tomsk Russia
| | - M. Nicolas
- Laboratory Psy-DREPI (EA 7458); University of Bourgogne Franche-Comté; Dijon France
| |
Collapse
|
21
|
Manuguerra A, Hubert J, Thouroude A, Thuret R, Beauval JB, Eschwege P, Doumerc N, Gamé X, Soulié M, Thoulouzan M, Roumiguié M, Nicolas M, Thibault F, Hubert N, Thi-Lambert PN. Compétences non techniques au bloc opératoire en chirurgie robotique et l’incidence des évènements porteurs de risque : une évaluation multicentrique. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Tostivint I, Royer N, Nicolas M, Bourillon A, Czerkiewicz I, Becker PH, Muller F, Benoist JF. Spectrum of mutations in cystinuria patients presenting with prenatal hyperechoic colon. Clin Genet 2017. [PMID: 28646536 DOI: 10.1111/cge.13079] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9. Antenatal hyperechoic colon (HEC) has been reported in some patients as a non-pathological consequence of the intestinal transport defect. We report 83 patients affected by cystinuria: 44 presented prenatally with a HEC (HEC group) and 39 with a classical postnatal form (CC group). SLC3A1 and SLC7A9 were sequenced. All patients were fully genotyped, and the relationship between the genotype and clinical features was analyzed. We identified mutations in SLC3A1 in 80% of the HEC group and in only 49% of the CC group. The SLC3A1 p.Thr216Met mutation was found in 21% of the alleles in the HEC group but was never found in the CC group. Most of the mutations found in the HEC group were considered severe mutations in contrast with the CC group. Twenty-five novel mutations were reported. This study shows a relationship between genotype and the clinical form of cystinuria, suggesting that only the patients with the most severe mutations presented with an HEC. These results emphasized the need for prenatal cystinuria screening using classical third-trimester ultrasound scan and the early management of suspected newborns.
Collapse
Affiliation(s)
- I Tostivint
- Department of Urology and Nephrology, Interdisciplinary Urolithiasis Center, Pitié-Salpêtrière Universitary Teaching Hospital, Paris, France
| | - N Royer
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - M Nicolas
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - A Bourillon
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - I Czerkiewicz
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - P-H Becker
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - F Muller
- Service de Biochimie Hormonologie, APHP, Paris, France
| | - J-F Benoist
- Service de Biochimie Hormonologie, APHP, Paris, France
| |
Collapse
|
23
|
Larivé E, Nicolas M, Schalenbourg A, Zografos L, Moulin A. β
-catenin activation in conjunctival melanocytic proliferations. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.03342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- E. Larivé
- Ophthalmology; Jules-gonin Eye Hospital; Lausanne Switzerland
| | - M. Nicolas
- Ophthalmology; Jules-gonin Eye Hospital; Lausanne Switzerland
| | - A. Schalenbourg
- Ophthalmology; Jules-gonin Eye Hospital; Lausanne Switzerland
| | - L. Zografos
- Ophthalmology; Jules-gonin Eye Hospital; Lausanne Switzerland
| | - A. Moulin
- Ophthalmology; Jules-gonin Eye Hospital; Lausanne Switzerland
| |
Collapse
|
24
|
Achit H, Nicolas M, Ngueyon W, Ladrière M, Hosseini K, Hubert J, Guillemin F. Évaluation de plusieurs techniques de prélèvement de rein chez le donneur vivant : une analyse médico-économique comparative. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.03.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
25
|
Mathonnet JE, Sornay P, Nicolas M, Dalloz-Dubrujeaud B. Compaction of noncohesive and cohesive granular materials under vibrations: Experiments and stochastic model. Phys Rev E 2017; 95:042904. [PMID: 28505849 DOI: 10.1103/physreve.95.042904] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2016] [Indexed: 06/07/2023]
Abstract
We study the time evolution of the compaction of a noncohesive or cohesive granular material submitted to shaking through experiments and a stochastic model. Beyond well-known empirical expressions, we show that the characteristic time scales depend on the number of objects in the assembly. For a noncohesive granular material, the compaction time scale is governed by the number of individual grains in the system. In the case of a cohesive granular material, a two-scale model (individual particles and clusters) allows one to mimic the time evolution of the compaction of an actual cohesive powder driven by horizontal vibrations. In this case, the two time scales are associated with the numbers of clusters and grains, respectively.
Collapse
Affiliation(s)
- J-E Mathonnet
- CEA, DEN, DEC, SFER, LCU, 13108 Saint-Paul-Lez-Durance, France
| | - P Sornay
- CEA, DEN, DEC, SFER, LCU, 13108 Saint-Paul-Lez-Durance, France
| | - M Nicolas
- Aix Marseille Univ, CNRS, IUSTI, Marseille, France
| | | |
Collapse
|
26
|
Pierre H, Mahasti S, Damien P, Nicolas M, Chritelle L, Florence D, Mony U, Lionel U, William J, Paule A, Audrey M, Claudia L, Mario C, Marie-Paule S, Marie-Ange MR, Marianne L, Jean-Christophe E, Thierry P, Jean-Marc F, Bruno C, Anthony G, Christian C, Gaëtane S, David P. Abstract P5-15-12: Real-life activity of oral vinorelbine in metastatic breast cancer patients in the Unicancer ESME database. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-15-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: In 2014, UNICANCER, composed of 18 French Comprehensive Cancer Centers, launched the Epidemiological Strategy and Medical Economics (ESME) program to investigate real-world data in oncology. Real-world data give the opportunity to assess the activity of specific products outside the framework of clinical trials. Oral vinorelbine (OV) is one of the therapeutic options available for metastatic breast cancer (mBC). Few data are available regarding its real clinical efficiency in current practice. We aimed at evaluating such activity within the ESME population.
Methods: The ESME-mBC database was built from information systems, treatment databases and patients' electronic files, with homogenous on-site collected information and high-level quality-control (Delaloge et al, Ann. Oncol 2016 (in press)). All patients having started a systemic treatment for mBC in a cancer center participating in the ESME program between 01-Jan-2008 and 31-Dec-2013 have been selected into the database.
For the purpose of the current analyses, data cut-off was July, 2015 and all patients who received OV at any time during the course of their disease were selected and analyzed. Primary end point was progression-free survival (PFS) from initiation of OV. Secondary end points were descriptive and prognostic analyses, and overall survival (OS).
Results: Among 13.853 patients recorded in the ESME-mBC database, 1402 received OV as a monotherapy or in combination (809 and 593 patients / 57.7% and 42.3% respectively). Most frequent combinations were with capecitabine (368 patients) and anti-HER2 therapy (165 patients). De-novo mBC was observed in 282 patients (20.1%) and 569 patients (40.6%) had only non-visceral metastases. At metastatic diagnosis, 221 patients (16.9%) had HER2-positive and 298 patients (22.9%) triple-negative tumors respectively. At OV initiation, median age was 59.0 [IC95%: 50-67] years. Endocrine therapy was given prior OV in 769 patients (54.9%). For PFS analysis, 1345 patients were evaluable. The following table summarizes PFS results according to the treatment patterns and the OV-line.
PFS results according to the treatment patterns and the OV-line OV-line 1st line2nd line3rd line4th line and moreOverall populationN320414313270Overall populationPFS (months, [IC95%])4.7 [4.2-5.5]3.3 [3.0-3.5]2.9 [2.6-3.2]2.3 [2.1-2.4]OV monotherapyN118223207202OV monotherapyPFS (months, [IC95%])4.3 [3.1-5.3]3.2 [2.9-3.5]2.8 [2.5-3.2]2.2 [2.0-2.4]OV in combination with capecitabineN1531294925OV in combination with capecitabinePFS (months, [IC95%])5.1 [3.9-6.1]3.5 [2.8-4.6]3.0 [2.4-4.7]2.0 [1.4-5.2]OV in combination with anti-HER2N41503826OV in combination with anti-HER2PFS (months, [IC95%])6.0 [4.1-7.9]3.1 [2.4-3.8]3.3 [2.4-6.0]2.7 [1.9-3.7]
Following diagnosis of mBC, median OS was 38.2 months [IC95%: 36.1-40.0] in the cohort of patients who received OV at any time.
Conclusions:This study allows large scale assessment of real life benefit of OV over subsequent lines and shows that OV yields clinical benefit even in heavily pre-treated mBC patients.
Citation Format: Pierre H, Mahasti S, Damien P, Nicolas M, Chritelle L, Florence D, Mony U, Lionel U, William J, Paule A, Audrey M, Claudia L, Mario C, Marie-Paule S, Marie-Ange M-R, Marianne L, Jean-Christophe E, Thierry P, Jean-Marc F, Bruno C, Anthony G, Christian C, Gaëtane S, David P. Real-life activity of oral vinorelbine in metastatic breast cancer patients in the Unicancer ESME database [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-15-12.
Collapse
Affiliation(s)
- H Pierre
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - S Mahasti
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - P Damien
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - M Nicolas
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - L Chritelle
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - D Florence
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - U Mony
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - U Lionel
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - J William
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - A Paule
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - M Audrey
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - L Claudia
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - C Mario
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - S Marie-Paule
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - M-R Marie-Ange
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - L Marianne
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - E Jean-Christophe
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - P Thierry
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - F Jean-Marc
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - C Bruno
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - G Anthony
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - C Christian
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - S Gaëtane
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| | - P David
- Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; Institut Jean Godinot, Reims, France; Institut Bergonié, Bordeaux, France; Centre François Baclesse, Caen, France; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris & Saint-Cloud, France; Institut de Cancérologie de Lorraine, Vandoeurvre-lès-Nancy, France; Institut du Cancer de Montpellier, Montpellier, France; Institut de Cancérologie de l'Ouest, Nantes & Angers, France; Centre Oscar Lambret, Lille, France; Centre Eugène Marquis, Rennes, France; Centre Jean Perrin, Clermont-Ferrand, France; Centre Henri Becquerel, Rouen, France; Centre Paul Strauss, Strasbourg, France; Centre Antoine Lacassagne, Nice, France; Centre Georges-François Leclerc, Dijon, France; Institut Paoli-Calmettes, Marseille, France; R&D Unicancer, Paris, France
| |
Collapse
|
27
|
Blaizot R, Melot B, Schepers K, Nicolas M, Gaumond S, Poullain P, Belaye L, Lannuzel A, Hoen B. Report of three imported cases of neurocysticercosis in Guadeloupe. BMC Infect Dis 2017; 17:106. [PMID: 28143423 PMCID: PMC5282648 DOI: 10.1186/s12879-016-2169-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2016] [Accepted: 12/24/2016] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Neurocysticercosis is endemic in most countries of Central and South America but has rarely been described in the French West Indies. We aimed to better understand the clinical and radiological presentation of our cases. CASE PRESENTATION We report three cases of neurocysticercosis in patients living in Guadeloupe, with different clinical and radiological presentations. CONCLUSION Given the eventuality of autochtonous transmission, the diagnosis should be considered in all patients living in Guadeloupe presenting with seizures.
Collapse
Affiliation(s)
- R. Blaizot
- Service de Maladies Infectieuses et Tropicales et Inserm-CIC 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - B. Melot
- Service de Maladies Infectieuses et Tropicales et Inserm-CIC 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - K. Schepers
- Service de Maladies Infectieuses et Tropicales et Inserm-CIC 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - M. Nicolas
- Laboratoire de Microbiologie clinique et environnementale, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - S. Gaumond
- Service d’anatomo-pathologie, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - P. Poullain
- Service de Radiologie, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - L. Belaye
- Service de Radiologie, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - A. Lannuzel
- Service de Neurologie, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
- Faculté de Médecine Antilles Guyane, Université des Antilles, EA 4537 Pointe-à-Pitre, Guadeloupe France
- Sorbonne University, UPMC Univ Paris 06, Inserm, CNRS, UM 75, U1127, ICM, Paris, F-75013 France
| | - B. Hoen
- Service de Maladies Infectieuses et Tropicales et Inserm-CIC 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
- Faculté de Médecine Antilles Guyane, Université des Antilles, EA 4537 Pointe-à-Pitre, Guadeloupe France
| |
Collapse
|
28
|
Achit H, Nicolas M, Ngueyon W, Ladriere M, Hosseini K, Hubert J, Guillemin F. Évaluation de plusieurs techniques de prélèvent de rein chez le donneur vivant : une analyse médico-économique comparative. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Kirsten N, Mailhol C, Lepage B, Laurent C, Tournier E, Eischen M, Konstantinou M, Ofaiche J, Nicolas M, Hautier-Mazereew J, Aquilina C, Marguery M, Boulinguez S, Giordano-Labadie F, Moreau J, Edvard S, Lamant L, Dubreuil P, Apoil P, Paul C, Bulai Livideanu C. Le choc anaphylactique dans une cohorte des patients atteints d’une pathologie mastocytaire. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
30
|
Moulin A, Schalenbourg A, Zografos L, Nicolas M. Cyclin kinase inhibitor p27 is downregulated in conjunctival melanoma. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A. Moulin
- Ophthalmology; Jules-Gonin Eye Hospital; Lausanne Switzerland
| | - A. Schalenbourg
- Ophthalmology; Jules-Gonin Eye Hospital; Lausanne Switzerland
| | - L. Zografos
- Ophthalmology; Jules-Gonin Eye Hospital; Lausanne Switzerland
| | - M. Nicolas
- Ophthalmology; Jules-Gonin Eye Hospital; Lausanne Switzerland
| |
Collapse
|
31
|
Lucas C, Nicolas M, Keller L. Expression of foraging and Gp-9 are associated with social organization in the fire ant Solenopsis invicta. Insect Mol Biol 2015; 24:93-104. [PMID: 25315753 DOI: 10.1111/imb.12137] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The aim of this study was to investigate levels of expression of two major genes, the odorant binding protein Gp-9 (general protein-9) and foraging, that have been shown to be associated with behavioural polymorphisms in ants. We analysed workers and young nonreproductive queens collected from nests of the monogyne (single reproductive queen per nest) and polygyne (multiple reproductive queens) social forms of Solenopsis invicta. In workers but not young queens, the level of foraging expression was significantly associated with social form and the task performed (ie localization in the nest or foraging area). The level of expression of Gp-9 was also associated with social form and worker localization. In addition there was a higher level of expression of the Gp-9(b) allele compared with the Gp-9(B) allele in the heterozygote workers and the young nonreproductive queens. Finally, in the polygyne colonies the level of expression of foraging was not significantly associated with the Gp-9 genotype for either workers or young nonreproductive queens, suggesting that both genes have independent non-epistatic effects on behaviour in S. invicta.
Collapse
Affiliation(s)
- C Lucas
- Department of Ecology and Evolution, University of Lausanne, Lausanne, Switzerland; Institut de Recherche sur la Biologie de l'Insecte (UMR 7261), CNRS, University of Tours, Tours, France
| | | | | |
Collapse
|
32
|
Gomes-Alves S, Alvarez M, Nicolas M, Martínez-Rodríguez C, Borragán S, Chamorro CA, Anel L, de Paz P. Salvaging urospermic ejaculates from brown bear (Ursus arctos). Anim Reprod Sci 2014; 150:148-57. [PMID: 25278437 DOI: 10.1016/j.anireprosci.2014.09.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2014] [Revised: 09/09/2014] [Accepted: 09/10/2014] [Indexed: 10/24/2022]
Abstract
The objective of this study was to reverse the osmotic stress of sperm in urine contaminated bear ejaculates that were obtained by electroejaculation using pre-freezing washing or density gradient centrifugation isolation. In Experiment 1, ejaculates were divided into six aliquots, five were diluted in each washing extender: 200, 300, 400, 500 and 700 mOsm/kg (prepared from a Tes-Tris-Fructose base, adding water or fructose as corresponds), at a 1:2 ratio (raw semen: washing solution, v/v); and the other aliquot was handled without washing (Control group). Samples were centrifuged at 600 × g for 6 min prior to freezing. In Experiment 2, ejaculates were divided into two aliquots: one was diluted 1:1 with TCG (Tris-Citric acid-Glucose) and centrifuged at 600 × g for 6 min (Centrifugation Control; C-Control); the other was treated with PureSperm density gradient column. After treatments, samples were cryopreserved. Sperm motility, viability (SYBR-14/propidium iodide (PI)) and acrosomal status (peanut agglutinin-fluorescein isothiocyanate (PNA-FITC)/PI) were analyzed before and after freezing. Ejaculates with an initial osmolality of less than 120 mOsm/kg treated with pre-freezing washing, and the Control sample had greater pre-freezing sperm motility than the raw ejaculate, but sperm viability was not different among these groups. The samples washed with 700 mOsm/kg solutions had the least pre-freezing viability. In the post-thawing evaluation, pre-freezing washing treatments did not provide any improvement in comparison with the Control sample, and treatment with 700 mOsm/kg extender had deleterious effects in all urospermic samples. PureSperm density gradient centrifugation applied to urospermic raw semen was suitable for improving sperm motility and viability of pre-freezing samples and the selected spermatozoa had greater freezing capacity.
Collapse
Affiliation(s)
- S Gomes-Alves
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Animal Reproduction and Obstetrics, University of León, 24071 León, Spain
| | - M Alvarez
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Animal Reproduction and Obstetrics, University of León, 24071 León, Spain
| | - M Nicolas
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Animal Reproduction and Obstetrics, University of León, 24071 León, Spain
| | - C Martínez-Rodríguez
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Cell Biology, University of León, 24071 León, Spain
| | | | - C A Chamorro
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain
| | - L Anel
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Animal Reproduction and Obstetrics, University of León, 24071 León, Spain
| | - P de Paz
- ITRA-ULE, INDEGSAL, University of León, 24071 León, Spain; Cell Biology, University of León, 24071 León, Spain.
| |
Collapse
|
33
|
Gomes-Alves S, Alvarez M, Nicolas M, Lopez -Urueña E, Martínez-Rodríguez C, Borragan S, de Paz P, Anel L. Use of commercial extenders and alternatives to prevent sperm agglutination for cryopreservation of brown bear semen. Theriogenology 2014; 82:469-74. [DOI: 10.1016/j.theriogenology.2014.05.015] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2013] [Revised: 05/09/2014] [Accepted: 05/12/2014] [Indexed: 11/30/2022]
|
34
|
De la Lama J, Fernandez J, Punzano J, Nicolas M, Nin S, Mengual R, Ramirez J, Raya AL, Ramos G. Using Six Sigma tools to improve internal processes in a hospital center through three pilot projects. International Journal of Healthcare Management 2013. [DOI: 10.1179/2047971913y.0000000044] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
35
|
Chroboczek T, Boisset S, Rasigade JP, Meugnier H, Akpaka PE, Nicholson A, Nicolas M, Olive C, Bes M, Vandenesch F, Laurent F, Etienne J, Tristan A. Major West Indies MRSA clones in human beings: do they travel with their hosts? J Travel Med 2013; 20:283-8. [PMID: 23992570 DOI: 10.1111/jtm.12047] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2012] [Revised: 03/27/2013] [Accepted: 04/22/2013] [Indexed: 11/28/2022]
Abstract
BACKGROUND Descriptions of the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) have seldom been produced in the Caribbean, which is a major tourism destination. MATERIALS AND METHODS Using DNA microarrays and spa typing, we characterized 85 MRSA isolates from human skin and soft-tissue infections from five different islands. RESULTS In the French West Indies (n = 72), the most frequently isolated clones were the same clones that are specifically isolated from mainland France [Lyon (n = 35) and Geraldine (n = 11) clones], whereas the clones that were most frequently isolated from the other islands (n = 13) corresponded with clones that have a worldwide endemic spread [Vienna/Hungarian/Brazilian (n = 5), Panton Valentine leukocidin-positive USA300 (n = 4), New York/Japan (n = 2), and pediatric (n = 1) clones]. CONCLUSION The distribution of the major MRSA clones in the French (Guadeloupe and Martinique) and non-French West Indies (Jamaica, Trinidad, and Tobago) is different, and the clones most closely resemble those found in the home countries of the travelers who visit the islands most frequently. The distribution might be affected by tourist migration, which is specific to each island.
Collapse
Affiliation(s)
- Tomasz Chroboczek
- French National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France; INSERM U851, Faculté de Médecine Lyon Est, University of Lyon, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Manoukian A, Quivet E, Temime-Roussel B, Nicolas M, Maupetit F, Wortham H. Emission characteristics of air pollutants from incense and candle burning in indoor atmospheres. Environ Sci Pollut Res Int 2013; 20:4659-4670. [PMID: 23288671 DOI: 10.1007/s11356-012-1394-y] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2012] [Accepted: 11/30/2012] [Indexed: 05/28/2023]
Abstract
Volatile organic compounds (VOCs) and particles emitted by incense sticks and candles combustion in an experimental room have been monitored on-line and continuously with a high time resolution using a state-of-the-art high sensitivity-proton transfer reaction-mass spectrometer (HS-PTR-MS) and a condensation particle counter (CPC), respectively. The VOC concentration-time profiles, i.e., an increase up to a maximum concentration immediately after the burning period followed by a decrease which returns to the initial concentration levels, were strongly influenced by the ventilation and surface interactions. The obtained kinetic data set allows establishing a qualitative correlation between the elimination rate constants of VOCs and their physicochemical properties such as vapor pressure and molecular weight. The emission of particles increased dramatically during the combustion, up to 9.1(±0.2) × 10(4) and 22.0(±0.2) × 10(4) part cm(-3) for incenses and candles, respectively. The performed kinetic measurements highlight the temporal evolution of the exposure level and reveal the importance of ventilation and deposition to remove the particles in a few hours in indoor environments.
Collapse
Affiliation(s)
- A Manoukian
- Aix Marseille Université, CNRS, LCE, FRE 3416, 13331 Marseille Cedex 03, France
| | | | | | | | | | | |
Collapse
|
37
|
Gandhi G, Allahbadia G, Kagalwala S, Allahbadia A, Ramesh S, Patel K, Hinduja R, Chipkar V, Madne M, Ramani R, Joo JK, Jeung JE, Go KR, Lee KS, Goto H, Hashimoto S, Amo A, Yamochi T, Iwata H, Morimoto Y, Koifman M, Lahav-Baratz S, Blais E, Megnazi-Wiener Z, Ishai D, Auslender R, Dirnfeld M, Zaletova V, Zakharova E, Krivokharchenko I, Zaletov S, Zhu L, Li Y, Zhang H, Ai J, Jin L, Zhang X, Rajan N, Kovacs A, Foley C, Flanagan J, O'Callaghan J, Waterstone J, Dineen T, Dahdouh EM, St-Michel P, Granger L, Carranza-Mamane B, Faruqi F, Kattygnarath TV, Gomes FLAF, Christoforidis N, Ioakimidou C, Papas C, Moisidou M, Chatziparasidou A, Klaver M, Tilleman K, De Sutter P, Lammers J, Freour T, Splingart C, Barriere P, Ikeno T, Nakajyo Y, Sato Y, Hirata K, Kyoya T, Kyono K, Campos FB, Meseguer M, Nogales M, Martinez E, Ariza M, Agudo D, Rodrigo L, Garcia-Velasco JA, Lopes AS, Frederickx V, Vankerkhoven G, Serneels A, Roziers P, Puttermans P, Campo R, Gordts S, Fragouli E, Alfarawati S, Spath K, Wells D, Liss J, Lukaszuk K, Glowacka J, Bruszczynska A, Gallego SC, Lopez LO, Vila EO, Garcia MG, Canas CL, Segovia AG, Ponce AG, Calonge RN, Peregrin PC, Hashimoto S, Amo A, Ito K, Nakaoka Y, Morimoto Y, Alcoba DD, Valerio EG, Conzatti M, Tornquist J, Kussler AP, Pimentel AM, Corleta HE, Brum IS, Boyer P, Montjean D, Tourame P, Gervoise-Boyer M, Cohen J, Lefevre B, Radio CI, Wolf JP, Ziyyat A, De Croo I, Tolpe A, Degheselle S, Van de Velde A, Tilleman K, De Sutter P, Van den Abbeel E, Kagalwala S, Gandhi G, Allahbadia G, Kuwayama M, Allahbadia A, Chipkar V, Khatoon A, Ramani R, Madne M, Alsule S, Inaba M, Ohgaki A, Ohtani A, Matsumoto H, Mizuno S, Mori R, Fukuda A, Morimoto Y, Umekawa Y, Yoshida A, Tanigiwa S, Seida K, Suzuki H, Tanaka M, Vahabi Z, Yazdi PE, Dalman A, Ebrahimi B, Mostafaei F, Niknam MR, Watanabe S, Kamihata M, Tanaka T, Matsunaga R, Yamanaka N, Kani C, Ishikawa T, Wada T, Morita H, Miyamura H, Nishio E, Ito M, Kuwahata A, Ochi M, Horiuchi T, Dal Canto M, Guglielmo MC, Fadini R, Renzini MM, Albertini DF, Novara P, Lain M, Brambillasca F, Turchi D, Sottocornola M, Coticchio G, Kato M, Fukunaga N, Nagai R, Kitasaka H, Yoshimura T, Tamura F, Hasegawa N, Nakayama K, Takeuchi M, Ohno H, Aoyagi N, Kojima E, Itoi F, Hashiba Y, Asada Y, Kikuchi H, Iwasa Y, Kamono T, Suzuki A, Yamada K, Kanno H, Sasaki K, Murakawa H, Matsubara M, Yoshida H, Valdespin C, Elhelaly M, Chen P, Pangestu M, Catt S, Hojnik N, Kovacic B, Roglic P, Taborin M, Zafosnik M, Knez J, Vlaisavljevic V, Mori C, Yabuuchi A, Ezoe K, Takayama Y, Aono F, Kato K, Radwan P, Krasinski R, Chorobik K, Radwan M, Stoppa M, Maggiulli R, Capalbo A, Ievoli E, Dovere L, Scarica C, Albricci L, Romano S, Sanges F, Barnocchi N, Papini L, Vivarelli A, Ubaldi FM, Rienzi L, Rienzi L, Bono S, Capalbo A, Spizzichino L, Rubio C, Ubaldi FM, Fiorentino F, Ferris J, Favetta LA, MacLusky N, King WA, Madani T, Jahangiri N, Aflatoonian R, Cater E, Hulme D, Berrisford K, Jenner L, Campbell A, Fishel S, Zhang XY, Yilmaz A, Hananel H, Ao A, Vutyavanich T, Piromlertamorn W, Saenganan U, Samchimchom S, Wirleitner B, Lejeune B, Zech NH, Vanderzwalmen P, Albani E, Parini V, Smeraldi A, Menduni F, Antonacci R, Marras A, Levi S, Morreale G, Pisano B, Di Biase A, Di Rosa A, Setti PEL, Puard V, Cadoret V, Tranchant T, Gauthier C, Reiter E, Guerif F, Royere D, Yoon SY, Eum JH, Park EA, Kim TY, Yoon TK, Lee DR, Lee WS, Cabal AC, Vallejo B, Campos P, Sanchez E, Serrano J, Remohi J, Nagornyy V, Mazur P, Mykytenko D, Semeniuk L, Zukin V, Guilherme P, Madaschi C, Bonetti TCS, Fassolas G, Izzo CR, Santos MJDL, Beltran D, Garcia-Laez V, Escriba MJ, Grau N, Escrich L, Albert C, Zuzuarregui JL, Pellicer A, LU Y, Nikiforaki D, Meerschaut FV, Neupane J, De Vos WH, Lierman S, Deroo T, Heindryckx B, De Sutter P, Li J, Chen XY, Lin G, Huang GN, Sun ZY, Zhong Y, Zhang B, Li T, Zhang SP, Ye H, Han SB, Liu SY, Zhou J, Lu GX, Zhuang GL, Muela L, Roldan M, Gadea B, Martinez M, Perez I, Meseguer M, Munoz M, Castello C, Asensio M, Fernandez P, Farreras A, Rovira S, Capdevila JM, Velilla E, Lopez-Teijon M, Kovacs P, Matyas SZ, Forgacs V, Reichart A, Rarosi F, Bernard A, Torok A, Kaali SG, Sajgo A, Pribenszky CS, Sozen B, Ozturk S, Yaba-Ucar A, Demir N, Gelo N, Stanic P, Hlavati V, ogoric S, Pavicic-Baldani D, prem-Goldtajn M, Radakovic B, Kasum M, Strelec M, Canic T, imunic V, Vrcic H, Ajina M, Negra D, Ben-Ali H, Jallad S, Zidi I, Meddeb S, Bibi M, Khairi H, Saad A, Escrich L, Grau N, Meseguer M, Gamiz P, Viloria T, Escriba MJ, Lima ET, Fernandez MP, Prieto JAA, Varela MO, Kassa D, Munoz EM, Morita H, Watanabe S, Kamihata M, Matsunaga R, Wada T, Kani K, Ishikawa T, Miyamura H, Ito M, Kuwahata A, Ochi M, Horiuchi T, Nor-Ashikin MNK, Norhazlin JMY, Norita S, Wan-Hafizah WJ, Mohd-Fazirul M, Razif D, Hoh BP, Dale S, Cater E, Woodhead G, Jenner L, Fishel S, Andronikou S, Francis G, Tailor S, Vourliotis M, Almeida PA, Krivega M, Van de Velde H, Lee RK, Hwu YM, Lu CH, Li SH, Vaiarelli A, Antonacci R, Smeraldi A, Desgro M, Albani E, Baggiani A, Zannoni E, Setti PEL, Kermavner LB, Klun IV, Pinter B, Vrtacnik-Bokal E, De Paepe C, Cauffman G, Verheyen G, Stoop D, Liebaers I, Van de Velde H, Stecher A, Wirleitner B, Vanderzwalmen P, Zintz M, Neyer A, Bach M, Baramsai B, Schwerda D, Zech NH, Wiener-Megnazi Z, Fridman M, Koifman M, Lahav-Baratz S, Blais I, Auslender R, Dirnfeld M, Akerud H, Lindgren K, Karehed K, Wanggren K, Hreinsson J, Rovira S, Capdevila JM, Freijomil B, Castello C, Farreras A, Fernandez P, Asensio M, Lopez-Teijon M, Velilla E, Weiss A, Neril R, Geslevich J, Beck-Fruchter R, Lavee M, Golan J, Ermoshkin A, Shalev E, Shi W, Zhang S, Zhao W, Xue XIA, Wang MIN, Bai H, Shi J, Smith HL, Shaw L, Kimber S, Brison D, Boumela I, Assou S, Haouzi D, Ahmed OA, Dechaud H, Hamamah S, Dasiman R, Nor-Shahida AR, Wan-Hafizah WJ, Norhazlin JMY, Mohd-Fazirul M, Salina O, Gabriele RAF, Nor-Ashikin MNK, Ben-Yosef D, Shwartz T, Cohen T, Carmon A, Raz NM, Malcov M, Frumkin T, Almog B, Vagman I, Kapustiansky R, Reches A, Azem F, Amit A, Cetinkaya M, Pirkevi C, Yelke H, Kumtepe Y, Atayurt Z, Kahraman S, Risco R, Hebles M, Saa AM, Vilches-Ferron MA, Sanchez-Martin P, Lucena E, Lucena M, Heras MDL, Agirregoikoa JA, Martinez E, Barrenetxea G, De Pablo JL, Lehner A, Pribenszky C, Murber A, Rigo J, Urbancsek J, Fancsovits P, Bano DG, Sanchez-Leon A, Marcos J, Molla M, Amorocho B, Nicolas M, Fernandez L, Landeras J, Adeniyi OA, Ehbish SM, Brison DR, Egashira A, Murakami M, Nagafuchi E, Tanaka K, Tomohara A, Mine C, Otsubo H, Nakashima A, Otsuka M, Yoshioka N, Kuramoto T, Choi D, Yang H, Park JH, Jung JH, Hwang HG, Lee JH, Lee JE, Kang AS, Yoo JH, Kwon HC, Lee SJ, Bang S, Shin H, Lim HJ, Min SH, Yeon JY, Koo DB, Kuwayama M, Higo S, Ruvalcaba L, Kobayashi M, Takeuchi T, Yoshida A, Miwa A, Nagai Y, Momma Y, Takahashi K, Chuko M, Nagai A, Otsuki J, Kim SG, Lee JH, Kim YY, Kim HJ, Park IH, Sun HG, Lee KH, Song HJ, Costa-Borges N, Belles M, Herreros J, Teruel J, Ballesteros A, Pellicer A, Calderon G, Nikiforaki D, Vossaert L, Meerschaut FV, Qian C, Lu Y, Parys JB, De Vos WH, Deforce D, Deroo T, Van den Abbeel E, Leybaert L, Heindryckx B, De Sutter P, Surlan L, Otasevic V, Velickovic K, Golic I, Vucetic M, Stankovic V, Stojnic J, Radunovic N, Tulic I, Korac B, Korac A, Fancsovits P, Pribenszky C, Lehner A, Murber A, Rigo J, Urbancsek J, Elias R, Neri QV, Fields T, Schlegel PN, Rosenwaks Z, Palermo GD, Gilson A, Piront N, Heens B, Vastersaegher C, Vansteenbrugge A, Pauwels PCP, Abdel-Raheem MF, Abdel-Rahman MY, Abdel-Gaffar HM, Sabry M, Kasem H, Rasheed SM, Amin M, Abdelmonem A, Ait-Allah AS, VerMilyea M, Anthony J, Bucci J, Croly S, Coutifaris C, Maggiulli R, Rienzi L, Cimadomo D, Capalbo A, Dusi L, Colamaria S, Baroni E, Giuliani M, Vaiarelli A, Sapienza F, Buffo L, Ubaldi FM, Zivi E, Aizenman E, Barash D, Gibson D, Shufaro Y, Perez M, Aguilar J, Taboas E, Ojeda M, Suarez L, Munoz E, Casciani V, Minasi MG, Scarselli F, Terribile M, Zavaglia D, Colasante A, Franco G, Greco E, Hickman C, Cook C, Gwinnett D, Trew G, Carby A, Lavery S, Asgari L, Paouneskou D, Jayaprakasan K, Maalouf W, Campbell BK, Aguilar J, Taboas E, Perez M, Munoz E, Ojeda M, Remohi J, Rega E, Alteri A, Cotarelo RP, Rubino P, Colicchia A, Giannini P, Devjak R, Papler TB, Tacer KF, Verdenik I, Scarica C, Ubaldi FM, Stoppa M, Maggiulli R, Capalbo A, Ievoli E, Dovere L, Albricci L, Romano S, Sanges F, Vaiarelli A, Iussig B, Gala A, Ferrieres A, Assou S, Vincens C, Bringer-Deutsch S, Brunet C, Hamamah S, Conaghan J, Tan L, Gvakharia M, Ivani K, Chen A, Pera RR, Bowman N, Montgomery S, Best L, Campbell A, Duffy S, Fishel S, Hirata R, Aoi Y, Habara T, Hayashi N, Dinopoulou V, Partsinevelos GA, Bletsa R, Mavrogianni D, Anagnostou E, Stefanidis K, Drakakis P, Loutradis D, Hernandez J, Leon CL, Puopolo M, Palumbo A, Atig F, Kerkeni A, Saad A, Ajina M, D'Ommar G, Herrera AK, Lozano L, Majerfeld M, Ye Z, Zaninovic N, Clarke R, Bodine R, Rosenwaks Z, Mazur P, Nagorny V, Mykytenko D, Semeniuk L, Zukin V, Zabala A, Pessino T, Outeda S, Blanco L, Leocata F, Asch R, Wan-Hafizah WJ, Rajikin MH, Nuraliza AS, Mohd-Fazirul M, Norhazlin JMY, Razif D, Nor-Ashikin MNK, Machac S, Hubinka V, Larman M, Koudelka M, Budak TP, Membrado OO, Martinez ES, Wilson P, McClure A, Nargund G, Raso D, Insua MF, Lotti B, Giordana S, Baldi C, Barattini J, Cogorno M, Peri NF, Neuspiller F, Resta S, Filannino A, Maggi E, Cafueri G, Ferraretti AP, Magli MC, Gianaroli L, Sioga A, Oikonomou Z, Chatzimeletiou K, Oikonomou L, Kolibianakis E, Tarlatzis BC, Sarkar MR, Ray D, Bhattacharya J, Alises JM, Gumbao D, Sanchez-Leon A, Amorocho B, Molla M, Nicolas M, Fernandez L, Landeras J, Duffy S, Campbell A, Montgomery S, Hickman CFL, Fishel S, Fiorentino I, Gualtieri R, Barbato V, Braun S, Mollo V, Netti P, Talevi R, Bayram A, Findikli N, Serdarogullari M, Sahin O, Ulug U, Tosun SB, Bahceci M, Leon AS, Gumbao D, Marcos J, Molla M, Amorocho B, Nicolas M, Fernandez L, Landeras J, Cardoso MCA, Aguiar APS, Sartorio C, Evangelista A, Gallo-Sa P, Erthal-Martins MC, Mantikou E, Jonker MJ, de Jong M, Wong KM, van Montfoort APA, Breit TM, Repping S, Mastenbroek S, Power E, Montgomery S, Duffy S, Jordan K, Campbell A, Fishel S, Findikli N, Aksoy T, Gultomruk M, Aktan A, Goktas C, Ulug U, Bahceci M, Petracco R, Okada L, Azambuja R, Badalotti F, Michelon J, Reig V, Kvitko D, Tagliani-Ribeiro A, Badalotti M, Petracco A, Pirkevi C, Cetinkaya M, Yelke H, Kumtepe Y, Atayurt Z, Kahraman S, Aydin B, Cepni I, Serdarogullari M, Findikli N, Bayram A, Goktas C, Sahin O, Ulug U, Bahceci M, Rodriguez-Arnedo D, Ten J, Guerrero J, Ochando I, Perez M, Bernabeu R, Okada L, Petracco R, Azambuja R, Badalotti F, Michelon J, Reig V, Tagliani-Ribeiro A, Kvitko D, Badalotti M, Petracco A, Reig V, Kvitko D, Tagliani-Ribeiro A, Okada L, Azambuja R, Petracco R, Michelon J, Badalotti F, Petracco A, Badalotti M. Embryology. Hum Reprod 2013. [DOI: 10.1093/humrep/det210] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Berguiga M, Mameletzi E, Nicolas M, Rivier D, Majo F. Long-term follow-up of multilayer amniotic membrane transplantation (MLAMT) for non-traumatic corneal perforations or deep ulcers with descemetocele. Klin Monbl Augenheilkd 2013; 230:413-8. [PMID: 23629794 DOI: 10.1055/s-0032-1328394] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND To evaluate the long-term efficacy of multilayer amniotic membrane transplantation for reconstruction of epithelium and stroma in non-traumatic corneal perforations (less than 2 mm) or deep ulcers with descemetocele. DESIGN Retrospective, non-comparative, interventional case series. PATIENTS AND METHODS Eleven consecutive patients with non-traumatic corneal perforations or deep corneal ulcers with descemetocele refractory to conventional treatments: herpetic or zoster keratitis (n = 4), Sjögren's syndrome (n = 2), rosacea (n = 1), hydrops (n = 1), mucous membrane pemphigoid (n = 1), bacterial keratitis (n = 1) and perforation after protontherapy for melanoma (n = 1). Intervention was: multilayer amniotic membrane transplantation with cryopreserved amniotic membrane. Complication rate and clinical outcome were evaluated in this long-term follow-up. RESULTS Mean follow-up was 32 months (12 to 60). Integration of the multilayer amniotic membrane was obtained in 10 cases after one year. Corneal epithelium healed above the membrane in 10 cases within 3 weeks and remained stable after 32 months in 9 cases. Thickness of the stroma was increased and remained stable during the follow-up in 9 cases. In one case herpetic keratitis recurred with a corneal perforation. The clearing of the amniotic membrane was gradually obtained over a period of 11 months. Complications occurred in 15% of the eyes during the long-term follow-up. CONCLUSION Multilayer amniotic membrane transplantation is a safe and efficient technique for a long restoration of the corneal integrity after non-traumatic corneal perforations or deep corneal ulcers with descemetocele. Long-term prognosis of these eyes depends of the gravity of the initial disease.
Collapse
Affiliation(s)
- M Berguiga
- Unité de la Cornée Médicale et Chirurgicale, Jules-Gonin Eye Hospital, Lausanne, Switzerland
| | | | | | | | | |
Collapse
|
39
|
Bourhy P, Herrmann Storck C, Theodose R, Olive C, Nicolas M, Hochedez P, Lamaury I, Zinini F, Brémont S, Landier A, Cassadou S, Rosine J, Picardeau M. Serovar diversity of pathogenic Leptospira circulating in the French West Indies. PLoS Negl Trop Dis 2013; 7:e2114. [PMID: 23516654 PMCID: PMC3597474 DOI: 10.1371/journal.pntd.0002114] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Accepted: 01/30/2013] [Indexed: 12/04/2022] Open
Abstract
Background Leptospirosis is one of the most important neglected tropical bacterial diseases in Latin America and the Caribbean. However, very little is known about the circulating etiological agents of leptospirosis in this region. In this study, we describe the serological and molecular features of leptospires isolated from 104 leptospirosis patients in Guadeloupe (n = 85) and Martinique (n = 19) and six rats captured in Guadeloupe, between 2004 and 2012. Methods and Findings Strains were studied by serogrouping, PFGE, MLVA, and sequencing 16SrRNA and secY. DNA extracts from blood samples collected from 36 patients in Martinique were also used for molecular typing of leptospires via PCR. Phylogenetic analyses revealed thirteen different genotypes clustered into five main clades that corresponded to the species: L. interrogans, L. kirschneri, L. borgpetersenii, L. noguchi, and L. santarosai. We also identified L. kmetyi in at least two patients with acute leptospirosis. This is the first time, to our knowledge, that this species has been identified in humans. The most prevalent genotypes were associated with L. interrogans serovars Icterohaemorrhagiae and Copenhageni, L. kirschneri serovar Bogvere, and L. borgpetersenii serovar Arborea. We were unable to identify nine strains at the serovar level and comparison of genotyping results to the MLST database revealed new secY alleles. Conclusions The overall serovar distribution in the French West Indies was unique compared to the neighboring islands. Typing of leptospiral isolates also suggested the existence of previously undescribed serovars. Leptospirosis is an emerging zoonotic disease caused by infection with pathogenic strains of Leptospira. Isolation of Leptospira strains is rare, making it difficult to assess their distribution worldwide. In this study, we characterized cultures of Leptospira obtained from more than one hundred leptospirosis patients from the French West Indies by serology and various molecular typing methods to identify the strains circulating in this endemic region. Typing of leptospiral isolates showed that causative agents of leptospirosis in the French West Indies are mainly from the serogroups Icterohaemorrhagiae and Ballum, but we also identified new genotypes. We also found that the distribution of the predominant pathogenic leptospiral serovars differed between the Caribbean islands. A better understanding of the epidemiology of leptospirosis will improve our knowledge in the distribution of this emerging neglected tropical disease worldwide. The identification of the circulating etiological agents of leptospirosis in the French West Indies will also help establish appropriate control and prevention measures in this area where the disease is endemic.
Collapse
Affiliation(s)
- Pascale Bourhy
- Institut Pasteur, Unité de Biologie des Spirochètes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
| | - Cécile Herrmann Storck
- University Hospital of Pointe à Pitre, Department of Bacteriology and Infectious and Tropical Diseases, Guadeloupe, French West Indies
| | - Rafaelle Theodose
- University Hospital of Fort de France, Department of Bacteriology and Infectious and Tropical Diseases, Martinique, French West Indies
| | - Claude Olive
- University Hospital of Fort de France, Department of Bacteriology and Infectious and Tropical Diseases, Martinique, French West Indies
| | - Muriel Nicolas
- University Hospital of Pointe à Pitre, Department of Bacteriology and Infectious and Tropical Diseases, Guadeloupe, French West Indies
| | - Patrick Hochedez
- University Hospital of Fort de France, Department of Bacteriology and Infectious and Tropical Diseases, Martinique, French West Indies
| | - Isabelle Lamaury
- University Hospital of Pointe à Pitre, Department of Bacteriology and Infectious and Tropical Diseases, Guadeloupe, French West Indies
| | - Farida Zinini
- Institut Pasteur, Unité de Biologie des Spirochètes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
| | - Sylvie Brémont
- Institut Pasteur, Unité de Biologie des Spirochètes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
| | - Annie Landier
- Institut Pasteur, Unité de Biologie des Spirochètes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
| | - Sylvie Cassadou
- French Institute for Public Health Surveillance (InVS), Interregional epidemiology unit of French West Indies (Cire Antilles-Guyane), Fort-de-France, Martinique, French West Indies
| | - Jacques Rosine
- French Institute for Public Health Surveillance (InVS), Interregional epidemiology unit of French West Indies (Cire Antilles-Guyane), Fort-de-France, Martinique, French West Indies
| | - Mathieu Picardeau
- Institut Pasteur, Unité de Biologie des Spirochètes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
- * E-mail:
| |
Collapse
|
40
|
Gok Oguz E, Olmaz R, Turgutalp K, Muslu N, Sungur MA, Kiykim A, Van Biesen W, Vanmassenhove J, Glorieux G, Vanholder R, Chew S, Forster K, Kaufeld T, Kielstein J, Schilling T, Haverich A, Haller H, Schmidt B, Hu P, Liang X, Liang X, Chen Y, LI R, Jiang F, LI Z, Shi W, Lim CCW, Lim CCW, Chia CML, Tan AK, Tan CS, Hu P, Liang X, Liang X, Chen Y, LI R, Jiang F, LI Z, Shi W, Ng R, Subramani S, Chew S, Perez de Jose A, Bernis Carro C, Madero Jarabo R, Bustamante J, Sanchez Tomero JA, Chung W, Ro H, Chang JH, Lee HH, Jung JY, Vanmassenhove J, Van Biesen W, Glorieux G, Vanholder R, Fazzari L, Giuliani A, Scrivano J, Pettorini L, Benedetto U, Luciani R, Roscitano A, Napoletano A, Coclite D, Cordova E, Punzo G, Sinatra R, Mene P, Pirozzi N, Shavit L, Shavit L, Manilov R, Algur N, Wiener-Well Y, Slotki I, Pipili C, Pipili C, Vrettou CS, Avrami K, Economidou F, Glynos K, Ioannidou S, Markaki V, Douka E, Nanas S, De Pascalis A, De Pascalis A, Cofano P, Proia S, Valletta A, Vitale O, Russo F, Buongiorno E, Filiopoulos V, Biblaki D, Lazarou D, Chrysis D, Fatourou M, Lafoyianni S, Vlassopoulos D, Zakiyanov O, Kriha V, Vachek J, Svarcova J, Zima T, Tesar V, Kalousova M, Kaushik M, Kaushik M, Ronco C, Cruz D, Zhang L, Zhang W, Zhang W, Chen N, Ejaz AA, Kambhampati G, Ejaz N, Dass B, Lapsia V, Arif AA, Asmar A, Shimada M, Alsabbagh M, Aiyer R, Johnson R, Chen TH, Chang CH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC, Cantaluppi V, Quercia AD, Figliolini F, Giacalone S, Pacitti A, Gai M, Guarena C, Leonardi G, Leonardi G, Biancone L, Camussi G, Segoloni GP, De Cal M, Lentini P, Clementi A, Virzi GM, Scalzotto E, Ronco C, Lacquaniti A, Lacquaniti A, Donato V, Fazio MR, Lucisano S, Cernaro V, Lupica R, Buemi M, Turgutalp K, Helvaci I, Anik E, Kiykim A, Wani M, Wani DI, Bhat DMA, Banday DK, Najar DMS, Reshi DAR, Palla DNA, Turgutalp K, Kiykim A, Helvaci I, Iglesias P, Olea T, Vega-Cabrera C, Heras M, Bajo MA, Del Peso G, Arias MJ, Selgas R, Diez JJ, Daher E, Costa PL, Pereira ENS, Santos RDP, Abreu KL, Silva Junior G, Pereira EDB, Raimundo M, Crichton S, Syed Y, Martin J, Whiteley C, Bennett D, Ostermann M, Gjyzari A, Thereska N, Koroshi A, Barbullushi M, Kodra S, Idrizi A, Strakosha A, Petrela E, Raimundo M, Crichton S, Syed Y, Martin J, Lemmich Smith J, Bennett D, Ostermann M, Klimenko A, Tuykhmenev E, Villevalde S, Kobalava Z, Avdoshina S, Villevalde S, Tyukhmenev E, Efremovtseva M, Kobalava Z, Hayashi H, Hayashi H, Suzuki S, Kataoka K, Kondoh Y, Taniguchi H, Sugiyama D, Nishimura K, Sato W, Maruyama S, Matsuo S, Yuzawa Y, Geraldine D, Muriel F, Alexandre H, Eric R, Fu P, Zhang L, Pozzato M, Ferrari F, Cecere P, Mesiano P, Vallero A, Livigni S, Quarello F, Hudier L, Decaux O, Haddj-Elmrabet A, Mandart L, Lino-Daniel M, Bridoux F, Renaudineau E, Sawadogo T, Le Pogamp P, Vigneau C, Famee D, Koo HM, Oh HJ, Han SH, Choi KH, Kang SW, Mehdi M, Nicolas M, Mariat C, Shah P, Kute VB, Vanikar A, Gumber M, Patel H, Trivedi H, Pipili C, Pipili C, Manetos C, Vrettou CS, Poulaki S, Tripodaki ES, Papastylianou A, Routsi C, Nanas S, Uchida K, Kensuke U, Yamagata K, Saitou C, Okada M, Chita G, Davies M, Veriawa Y, Naicker S, Mukhopadhyay P, Mukherjee D, Mishra R, Kar M, Zickler D, Wesselmann H, Schindler R, Gutierrez* E, Egido J, Rubio-Navarro A, Buendia I, Blanco-Colio LM, Toldos O, Manzarbeitia F, De Lorenzo A, Sanchez R, Praga^ M, Moreno^ JA, Kim MY, Kang NR, Jang HR, Lee JE, Huh W, Kim YG, Kim DJ, Hong SC, Kim JS, Oh HY, Okamoto T, Kamata K, Naito S, Tazaki H, Kan S, Anne-Kathrin LG, Matthias K, Speer T, Andreas L, Heinrich G, Thomas V, Poppleton A, Danilo F, Matthias K, Lai CF, Wu VC, Shiao CC, Huang TM, Wu KD, Bedford M, Farmer C, Irving J, Stevens P, Patera F, Patera F, Mattozzi F, Battistoni S, Fagugli RM, Park MY, Choi SJ, Kim JG, Hwang SD, Xie H, Chen H, Xu S, He Q, Liu J, Hu W, Liu Z, Dalboni M, Blaya R, Quinto BM, Narciso R, Oliveira M, Monte J, Durao M, Cendoroglo M, Batista M, Hanemann AL, Liborio A, Daher E, Martins A, Pinheiro MCC, Silva Junior G, Meneses G, De Paula Pessoa R, Sousa M, Bezerra FSM, Albuquerque PLMM, Lima JB, Lima CB, Veras MDSB, Silva Junior G, Daher E, Nemoto Matsui T, Totoli C, Cruz Andreoli MC, Vilela Coelho MP, Guimaraes de Souza NK, Ammirati AL, De Carvalho Barreto F, Ferraz Neto BH, Fortunato Cardoso Dos Santos B, Abraham A, Abraham G, Mathew M, Duarte PMA, Duarte FB, Barros EM, Castro FQS, Silva Junior G, Daher E, Palomba H, Castro I, Sousa SR, Jesus AN, Romano T, Burdmann E, Yu L, Kwon SH, You JY, Hyun YK, Woo SA, Jeon JS, Noh HJ, Han DC, Tozija L, Tozija L, Petronievic Z, Selim G, Nikolov I, Stojceva-Taneva O, Cakalaroski K, Lukasz A, Beneke J, Schmidt B, Kielstein J, Haller H, Menne J, Schiffer M, Polanco N, Hernandez E, Gutierrez E, Gutierrez Millet V, Gonzalez Monte E, Morales E, Praga M, Francisco Javier L, Nuria GF, Jose Maria MG, Bes Rastrollo M, Angioi A, Conti M, Cao R, Atzeni A, Pili G, Matta V, Murgia E, Melis P, Binda V, Pani A, Thome* F, Leusin F, Barros E, Morsch C, Balbinotto A, Pilla C, Premru V, Buturovic-Ponikvar J, Ponikvar R, Marn-Pernat A, Knap B, Kovac J, Gubensek J, Kersnic B, Krnjak L, Prezelj M, Granatova J, Havrda M, Hruskova Z, Kratka K, Remes O, Mokrejsova M, Bolkova M, Lanska V, Rychlik I, Uniacke MD, Lewis RJ, Harris S, Roderick P, Thome* F, Balbinotto A, Barros E, Morsch C, Martin N, Ulrich K, Jan B, Jorn B, Reinhard B, Jan K, Hermann H, Meyer Tobias F, Leyla R, Schmidt Bernhard MW, Harald S, Jurgen S, Tanja K, Menne J, Mario S, Jan B, Jan B, Sang Hi E, Leyla R, Claus M, Frank V, Aleksej S, Sengul S, Jan K, Jorn B, Reinhard B, Meyer Tobias F, Schmidt Bernhard MW, Mario S, Martin N, Ulrich K, Robert S, Karin W, Tanja K, Hermann H, Menne J, Leyla R, Leyla R, Jan K, Jan B, Reinhard B, Feikah G, Hermann H, Tanja K, Ulrich K, Menne Tobias F, Claus M, Martin N, Mario S, Schmidt Bernhard MW, Harald S, Jurgen S, Menne J, Claus M, Claus M, Jan K, Jan B, Reinhard B, Feikah G, Hermann H, Ulrich K, Menne Tobias F, Meyer Tobias N, Martin N, Leyla R, Schmidt Bernhard MW, Harald S, Jurgen S, Tanja K, Mario S, Menne J, Kielstein J, Beutel G, Fleig S, Steinhoff J, Meyer T, Hafer C, Bramstedt J, Busch V, Vischedyk M, Kuhlmann U, Ries W, Mitzner S, Mees S, Stracke S, Nurnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn E, Samuelsson O, Brunkhorst R, Stec-Hus Registry G, Reising A, Hafer C, Kielstein J, Schmidt B, Bange FC, Hiss M, Vetter F, Kielstein J, Beneke J, Bode-Boger SM, Martens-Lobenhoffer J, Schiffer M, Schmidt BMW, Haller H, Menne J, Kielstein JT, Shin HS, Jung YS, Rim H. AKI - Clinical. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Bonani M, Brockmann J, Cohen CD, Fehr T, Nocito A, Schiesser M, Serra AL, Blum M, Struker M, Frey DF, Wuthrich RP, Kim YW, Park SJ, Kim TH, Kim YH, Kang SW, Webb L, Casula A, Tomson C, Ben-Shlomo Y, Webb L, Casula A, Ben-Shlomo Y, Tomson C, Mansour H, Akl A, Wafa E, El Shahawy M, Palma R, Swaminathan S, Irish AB, Kolonko A, Chudek J, Wiecek A, Vanrenterghem Y, Kuypers D, Katrien DV, Evenepoel P, Claes K, Bammens B, Meijers B, Naesens M, Kolonko A, Chudek J, Wiecek A, Lo S, Chan CK, Yong D, Wong PN, Kwan TH, Cheng YL, Fung KS, Choy BY, Chau KF, Leung CB, Ebben J, Liu J, Chen SC, Collins A, Ho YW, Abelli M, Ferrario DI Torvajana A, Ticozzelli E, Maiga B, Ferrario DI Torvajana A, Patane A, Albrizio P, Gregorini M, Libetta C, Rampino T, Albrizio P, Geraci P, Dal Canton A, Rotter MT, Jacobi J, Pressmar K, Amann K, Eckardt KU, Weidemann A, Muller K, Stein M, Diezemann C, Sefrin A, Babel N, Reinke P, Schachtner T, Costa C, Touscoz GA, Sidoti F, Sinesi F, Mantovani S, Simeone S, Balloco C, Piasentin Alessio E, Messina M, Segoloni G, Cavallo R, Sharma R.K, Kaul DA, Gupta RK, Gupta A, Prasad N, Bhadhuria D, Suresh KJ, Benaboud S, Prie D, Thervet E, Urien S, Legendre C, Souberbielle JC, Hirt D, Friedlander G, Treluyer JM, Courbebaisse M, Arias M, Arias M, Campistol J, Pascual J, Grinyo JM, Hernandez D, Morales JM, Pallardo LM, Seron D, Senecal L, Boucher A, Dandavino R, Boucher A, Colette S, Vallee M, Lafrance JP, Tung-Min Y, Min-Ju W, Cheng-Hsu C, Chi-Hung C, Kuo-Hsiung S, Mei-Chin W, Direkze S, Khorsavi M, Khorsavi M, Stuart S, Goode A, Jones G, Chudek J, Kolonko A, Wiecek A, Massimetti C, Napoletano I, Imperato G, Muratore MT, Fazio S, Pessina G, Brescia F, Feriozzi S, Tanaka K, Sakai K, Futaki A, Hyoudo Y, Muramatsu M, Kawamura T, Shishido S, Hara S, Kushiyama A, Aikawa A, Jankowski K, Gozdowska J, Lewandowska D, Kwiatkowski A, Durlik M, Pruszczyk P, Obi Y, Ichimaru N, Kato T, Okumi M, Kaimori J, Yazawa K, Nonomura N, Isaka Y, Takahara S, Aimele M, Christophe R, Geraldine D, Eric R, Alexandre H, Masson I, Nicolas M, Ivan T, Acil J, Lise T, Aoumeur HA, Laurence D, Pierre D, Etienne C, Lionel R, Nassim K, Emmanuel M, Eric A, Christophe M, Webb L, Casula A, Tomson C, Ben-Shlomo Y, Alexandre K, Pierre B, Jean-Philippe H, Dominique P, Christophe L, Alexei G, Michel D, Shah P, Kute VB, Vanikar A, Gumber M, Modi P, Trivedi H, GoIebiewska J, Debska-Slizien A, Rutkowski B, Domanski L, Dutkiewicz G, Kloda K, Pawlik A, Ciechanowicz A, Binczak-Kuleta A, Rozanski J, Myslak M, Safranow K, Ciechanowski K, Aline CS, Basset T, Delavenne X, Alamartine E, Mariat C, Kloda K, Domanski L, Pawlik A, Bobrek-Lesiakowska K, Wisniewska M, Romanowski M, Safranow K, Kurzawski M, Rozanski J, Myslak M, Ciechanowski K, De Borst M, Baia L, Navis G, Bakker S, Ranghino A, Tognarelli G, Basso E, Messina M, Manzione AM, Daidola G, Segoloni GP, Kimura T, Yagisawa T, Ishikawa N, Sakuma Y, Hujiwara T, Nukui A, Yashi M, Kim JH, Kim SS, Han DJ, Park SK, Randhawa G, Gumber M, Kute VB, Shah P, Patel H, Vanikar A, Modi P, Trivedi H, Taheri S, Goker-Alpan O, Ibrahim J, Nedd K, Shankar S, Lein H, Barshop B, Boyd E, Holida M, Hillman R, Ibrahim J, Mardach R, Wienreb N, Rever B, Forte R, Desai A, Wijatyk A, Chang P, Martin R. Transplantation - clinical I. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Riegersperger M, Plischke M, Steiner-Boker S, Seidinger D, Winkelmayer W, Sunder-Plassmann G, Vlahovic P, Vlahovic P, Cvetkovic T, Djordjevic V, Velickovic-Radovanovic R, Stefanovic N, Ignjatovic A, Sladojevic N, Cademartori V, Massarino F, Parodi EL, Russo R, Sofia A, Fontana I, Viviani GL, Garibotto G, Mai M, Mai W, Taner B, Wadei H, Prendergast M, Gonwa T, Martin J, Martin J, Aurore S, Aline CS, Nicolas M, Manolie M, Catherine S, Eric A, Christophe M, Brakemeier S, Liefeldt L, Glander P, Waiser J, Lachmann N, Schonemann C, Zukunft B, Illigens P, Schmidt D, Wu K, Rudolph B, Neumayer HH, Budde K, Pallardo Mateu L, Gavela Martinez E, Sancho Calabuig A, Crespo Albiach J, Beltran Catalan S, Gavela Martinez E, Kanter Berga J, Kimura T, Yagisawa T, Ishikawa N, Sakuma Y, Hujiwara T, Nukui A, Yashi M, Duraes J, Malheiro J, Fonseca I, Rocha A, Martins LS, Almeida M, Dias L, Castro-Henriques A, Cabrita A, Mai M, Mai W, Wadei H, Prendergast M, Gonwa T, Volpe A, Quaglia M, Menegotto A, Fenoglio R, Izzo C, Airoldi A, Terrone C, Stratta P, Ahmed B, Mireille K, Nilufer B, Annick M, Karl Martin W, Anh-Dung H, Dimitri M, Philippe M, Judith R, Daniel A, Liefeldt L, Glander P, Glander P, Lan Y, Schmidt D, Heine C, Budde K, Neumayer HH, Schmidt D, Glander P, Glander P, Budde K, Neumayer HH, Liefeldt L, Quaglia M, Quaglia M, Capone V, Izzo C, Menegotto A, Fenoglio R, Airoldi A, Stratta P, Grace B, Clayton P, Cass A, Mcdonald S, Yagisawa T, Yagisawa T, Yashi M, Kimura T, Nukui A, Fujiwara T, Sakuma Y, Ishikawa N, Iwabuchi T, Muraishi O, Torregrosa V, Barros X, Martinez de Osaba MJ, Paschoalin R, Campistol JM, Hassan R, El-Hefnawy A, Soliman S, Shokeir A, Cobanoglu Kudu A, Gungor O, Kircelli F, Altinel E, Asci G, Ozbek SS, Toz H, Ok E, Sandrini S, Setti G, Valerio F, Possenti S, Torrisi I, Polanco N, Garcia-Puente L, Gonzalez Monte E, Morales E, Gutierrez E, Bengoa I, Hernandez A, Caballero J, Morales JM, Andres A, Sgarlato V, Sgarlato V, Comai G, La Manna G, Moretti I, Grandinetti V, Martelli D, Scolari MP, Stefoni S, Valentini C, Valentini C, Persici E, La Manna G, Cappuccilli ML, Sgarlato V, Liviano D'arcangelo G, Fabbrizio B, Carretta E, Mosconi G, Scolari MP, Feliciangeli G, Grigioni FW, Stefoni S, Apicella L, Guida B, Vitale S, Garofalo G, Russo L, Maresca I, Rossano R, Memoli B, Carrano R, Federico S, Sabbatini M, Carta P, Zanazzi M, DI Maria L, Caroti L, Miejshtri A, Tsalouchos A, Bertoni E, Sezer S, Erkmen Uyar M, Colak T, Bal Z, Tutal E, Kalaci G, Ozdemir Acar FN, Jacquelinet C, Bayat S, Pernin V, Portales P, Szwarc I, Garrigue V, Vetromile F, Delmas S, Eliaou JF, Mourad G, Huber L, Huber L, Slowinski T, Naik M, Glander P, Liefeldt L, Schmidt D, Neumayer HH, Budde K, Nakai K, Fujii H, Kono K, Goto S, Ishimura T, Takeda M, Fujisawa M, Nishi S, Pereira Paschoalin R, Paschoalin R, Torregrosa JV, Barros Freiria X, Duran Rebolledo CE, Sanchez Escuredo A, Sole M, Campistol JM, Youssouf S, Tabbasm F, Bell R, Al-Jayyousi R, Warwick G, Grall A, Treguer L, Essig M, Lecaque C, Noel N, Buchler M, Bertrand D, Rivalan J, Braun L, Villemain F, Hurault de Ligny B, Totet A, Pestourie N, Toubas D, Nevez G, Le Meur Y, Nour el Houda B, Mustapha H, Wafaa F, Inass L, Rambabova Bushljetikj I, Rambabova Bushljetikj I, Masin-Spasovska J, Spasovski G, Popov Z, Sikole A, Ivanovski N, Raimundo M, Guerra J, Teixeira C, Santana A, Silva S, Mil Homens C, Gomes Da Costa A, Loredo D, Cleres M, Gondolesi G, Gutierrez LM, Fortunato RM, Descalzi V, Raffaele P. Transplantation - clinical II. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Nicolas M, Alvarez M, Borragán S, Martinez-Pastor F, Chamorro CA, Alvarez-Rodriguez M, de Paz P, Anel L. Evaluation of the qualitative and quantitative effectiveness of three media of centrifugation (Maxifreeze, Cushion Fluid Equine, and PureSperm 100) in preparation of fresh or frozen-thawed brown bear spermatozoa. Theriogenology 2011; 77:1119-28. [PMID: 22154477 DOI: 10.1016/j.theriogenology.2011.10.016] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2011] [Revised: 09/28/2011] [Accepted: 10/08/2011] [Indexed: 11/19/2022]
Abstract
Centrifugation is a crucial procedure in sperm cryopreservation protocols of brown bear (Ursus arctos), because the semen must be processed to increase sperm concentration and/or clean urine-contaminated samples. The efficacy of three media for centrifugation (Maxifreeze [IMV technologies, L'Aigle, France], Cushion Fluid Equine (Minitübe, Tiefenbach, Germany), and PureSperm [Nidacon, Gothenburg, Sweden]) on the quality of bear spermatozoa was evaluated. In experiment one, two cushioned media used for protecting against mechanical stress during centrifugation were analyzed. In experiment two, a density gradient based on PureSperm was assessed in relation to the maximum retrieval and the quality of fresh spermatozoa, and the freezability of the spermatozoa selected in this density gradient was studied in experiment three. Finally, the selection of frozen-thawed sperm using PureSperm was analyzed in experiment four. Our results indicate that the use of dense isotonic cushion solutions (Maxifreeze, Cushion Fluid Equine) in centrifugation did not improve the quality of recovered spermatozoa compared with standard centrifugation. However, a density gradient prepared with PureSperm improved the quality of spermatozoa in fresh semen and frozen-thawed semen, but the spermatozoa selected from the fresh sample with this density gradient did not show a better resistance to freezing with this density gradient in comparison with the control sample.
Collapse
Affiliation(s)
- M Nicolas
- ITRA-ULE, INDEGSAL, University of León, León, Spain
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Tamayo-Canul J, Alvarez M, López-Urueña E, Nicolas M, Martinez-Pastor F, Anel E, Anel L, de Paz P. Undiluted or extended storage of ram epididymal spermatozoa as alternatives to refrigerating the whole epididymes. Anim Reprod Sci 2011; 126:76-82. [DOI: 10.1016/j.anireprosci.2011.04.011] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2010] [Revised: 04/11/2011] [Accepted: 04/20/2011] [Indexed: 11/25/2022]
|
45
|
de Paz P, Alvarez-Rodriguez M, Nicolas M, Alvarez M, Chamorro CA, Borragán S, Martinez-Pastor F, Anel L. Optimization of Glycerol Concentration and Freezing Rate in the Cryopreservation of Ejaculate From Brown Bear (Ursus arctos). Reprod Domest Anim 2011; 47:105-12. [DOI: 10.1111/j.1439-0531.2011.01808.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
46
|
El Hajjaji I, Nicolas M, El Mahmoud R, Digne F, Dubourg O. Prevalence of coronary artery spasm during dobutamine stress echocardiography. Arch Cardiovasc Dis 2011. [DOI: 10.1016/j.acvd.2011.03.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Fourati Ben Mustapha S, Khrouf M, Kacem Ben Rejeb K, Elloumi Chaabene H, Merdassi G, Wahbi D, Ben Meftah M, Zhioua F, Zhioua A, Azzarello A, Host T, Mikkelsen AL, Theofanakis CP, Dinopoulou V, Mavrogianni D, Partsinevelos GA, Drakakis P, Stefanidis K, Bletsa A, Loutradis D, Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Garrido N, Remohi J, Ragni G, Ubaldi FM, Herrer R, Quera M, GIL E, Serna J, Grondahl ML, Bogstad J, Agerholm IE, Lemmen JG, Bentin-Ley U, Lundstrom P, Kesmodel US, Raaschou-Jensen M, Ladelund S, Guzman L, Ortega C, Albuz FK, Gilchrist RB, Devroey P, Smitz J, De Vos M, Bielanska M, Leveille MC, Borghi E, Magli MC, Figueroa MJ, Mascaretti G, Ferraretti AP, Gianaroli L, Szlit E, Leocata Nieto F, Maggiotto G, Arenas G, Tarducci Bonfiglio N, Ahumada A, Asch R, Sciorio R, Dayoub N, Thong J, Pickering S, Ten J, Carracedo MA, Guerrero J, Rodriguez-Arnedo A, Llacer J, Bernabeu R, Tatone C, Heizenrieder T, Di Emidio G, Treffon P, Seidel T, Eichenlaub-Ritter U, Cortezzi SS, Cabral EC, Ferreira CR, Trevisan MG, Figueira RCS, Braga DPAF, Eberlin MN, Iaconelli Jr. A, Borges Jr. E, Zabala A, Pessino T, Blanco L, Rey Valzacchi G, Leocata F, Ahumada A, Vanden Meerschaut F, Heindryckx B, Qian C, Deforce D, Leybaert L, De Sutter P, De las Heras M, De Pablo JL, Navarro B, Agirregoikoa JA, Barrenetxea G, Cruz M, Perez-Cano I, Gadea B, Herrero J, Martinez M, Roldan M, Munoz M, Pellicer A, Meseguer M, Munoz M, Cruz M, Roldan M, Gadea B, Galindo N, Martinez M, Pellicer A, Meseguer M, Perez-Cano I, Scarselli F, Alviggi E, Colasante A, Minasi MG, Rubino P, Lobascio M, Ferrero S, Litwicka K, Varricchio MT, Giannini P, Piscitelli P, Franco G, Zavaglia D, Nagy ZP, Greco E, Urner F, Wirthner D, Murisier F, Mock P, Germond M, Amorocho Llanos B, Calderon G, Lopez D, Fernandez L, Nicolas M, Landeras J, Finn-Sell SL, Leandri R, Fleming TP, Macklon NS, Cheong YC, Eckert JJ, Lee JH, Jung YJ, Hwang HK, Kang A, An SJ, Jung JY, Kwon HC, Lee SJ, Palini S, Zolla L, De Stefani S, Scala V, D'Alessandro A, Polli V, Rocchi P, Tiezzi A, Pelosi E, Dusi L, Bulletti C, Fadini R, Lain M, Mignini Renzini M, Brambillasca F, Coticchio G, Merola M, Guglielmo MC, Dal Canto M, Figueira R, Setti AS, Braga DPAF, Iaconelli Jr. A, Borges Jr. E, Worrilow KC, Uzochukwu CD, Eid S, Le Gac S, Esteves TC, van Rossem F, van den Berg A, Boiani M, Kasapi E, Panagiotidis Y, Goudakou M, Papatheodorou A, Pasadaki T, Prapas N, Prapas Y, Panagiotidis Y, Kasapi E, Goudakou M, Papatheodorou A, Pasadaki T, Vanderzwalmen P, Prapas N, Prapas Y, Norasing S, Atchajaroensatit P, Tawiwong W, Thepmanee O, Saenlao S, Aojanepong J, Hunsajarupan P, Sajjachareonpong K, Punyatanasakchai P, Maneepalviratn S, Jetsawangsri U, Herrero J, Cruz M, Tejera A, Rubio I, Romero JL, Meseguer M, Nordhoff V, Schlatt S, Schuring AN, Kiesel L, Kliesch S, Azambuja R, Okada L, Lazzari V, Dorfman L, Michelon J, Badalotti M, Badalotti F, Petracco A, Schwarzer C, Esteves TC, Nordhoff V, Schlatt S, Boiani M, Versieren K, Heindryckx B, De Croo I, Lierman S, De Vos W, Van den Abbeel E, Gerris J, De Sutter P, Milacic I, Borogovac D, Veljkovic M, Arsic B, Jovic Bojovic D, Lekic D, Pavlovic D, Garalejic E, Guglielmo MC, Coticchio G, Albertini DF, Dal Canto M, Brambillasca F, Mignini Renzini M, De Ponti E, Fadini R, Sanges F, Talevi R, Capalbo A, Papini L, Mollo V, Ubaldi FM, Rienzi LF, Gualtieri R, Albuz FK, Guzman L, Orteg C, Gilchrist RB, Devroey P, De Vos M, Smitz J, Choi J, Lee H, Ku S, Kim S, Choi Y, Kim J, Moon S, Demilly E, Assou S, Moussaddykine S, Dechaud H, Hamamah S, Takisawa T, Doshida M, Hattori H, Nakamura Y, Kyoya T, Shibuya Y, Nakajo Y, Tasaka A, Toya M, Kyono K, Novo S, Penon O, Gomez R, Barrios L, Duch M, Santalo J, Esteve J, Nogues C, Plaza JA, Perez-Garcia L, Ibanez E, Chavez S, Loewke K, Behr B, Reijo Pera R, Huang S, Wang H, Soong Y, Chang C, Okimura T, Kuwayama M, Mori C, Morita M, Uchiyama K, Aono F, Kato K, Takehara Y, Kato O, Minasi M, Casciani V, Scarselli F, Rubino P, Colasante A, Arizzi L, Litwicka K, Ferrero S, Mencacci C, Piscitelli C, Giannini P, Cucinelli F, Tocci A, Nagy ZP, Greco E, Wydooghe E, Vandaele L, Dewulf J, Van den Abbeel E, De Sutter P, Van Soom A, Moon JH, Son WY, Mahfoudh A, Henderson S, Jin SG, Shalom-Paz E, Dahan M, Holzer H, Mahmoud K, Triki-Hmam C, Terras K, Zhioua F, Hfaiedh T, Ben Aribia MH, Otsubo H, Egashira A, Tanaka K, Matsuguma T, Murakami M, Murakami K, Otsuka M, Yoshioka N, Araki Y, Kuramoto T, Smit JG, Sterrenburg MD, Eijkemans MJC, Al-Inany HG, Youssef MAFM, Broekmans FJM, Willoughby K, DiPaolo L, Deys L, Lagunov A, Amin S, Faghih M, Hughes E, Karnis M, Ashkar F, King WA, Neal MS, Antonova I, Veleva L, Petkova L, Shterev A, Nogales C, Martinez E, Ariza M, Cernuda D, Gaytan M, Linan A, Guillen A, Bronet F, Cottin V, Fabian D, Allemann F, Koller A, Spira JC, Agudo D, Martinez-Burgos M, Arnanz A, Basile N, Rodriguez A, Bronet F, Cho YS, Filioli Uranio M, Ambruosi B, Paternoster MS, Totaro P, Sardanelli AM, Dell'Aquila ME, Zollner U, Hofmann T, Zollner KP, Kovacic B, Roglic P, Vlaisavljevic V, Sole M, Santalo J, Boada M, Coroleu B, Veiga A, Martiny G, Molinari M, Revelli A, Chimote NM, Chimote M, Mehta B, Chimote NN, Sheikh N, Nath N, Mukherjee A, Rakic K, Reljic M, Kovacic B, Vlaisavljevic V, Ingerslev HJ, Kirkegaard K, Hindkjaer J, Grondahl ML, Kesmodel US, Agerholm I, Kitasaka H, Fukunaga N, Nagai R, Yoshimura T, Tamura F, Kitamura K, Hasegawa N, Nakayama K, Katou M, Itoi F, Asano E, Deguchi N, Ooyama K, Hashiba Y, Asada Y, Michaeli M, Rotfarb N, Karchovsky E, Ruzov O, Atamny R, Slush K, Fainaru O, Ellenbogen A, Chekuri S, Chaisrisawatsuk T, Chen P, Pangestu M, Jansen S, Catt S, Molinari E, Racca C, Revelli A, Ryu C, Kang S, Lee J, Chung D, Roh S, Chi H, Yokota Y, Yokota M, Yokota H, Sato S, Nakagawa M, Komatsubara M, Makita M, Araki Y, Yoshimura T, Asada Y, Fukunaga N, Nagai R, Kitasaka H, Itoi F, Tamura F, Kitamura K, Hasegawa N, Katou M, Nakayama K, Asano E, Deguchi N, Oyama K, Hashiba Y, Naruse K, Kilani S, Chapman MG, Kwik M, Chapman M, Guven S, Odaci E, Yildirim O, Kart C, Unsal MA, Yulug E, Isachenko E, Maettner R, Strehler E, Isachenko V, Hancke K, Kreienberg R, Sterzik K, Coticchio G, Guglielmo MC, Dal Canto M, Albertini DF, Brambillasca F, Mignini Renzini M, Fadini R, Zheng XY, Wang LN, Liu P, Qiao J, Inoue F, Dashtizad M, Wahid H, Rosnina Y, Daliri M, Hajarian H, Akbarpour M, Abbas Mazni O, Knez K, Tomaevic T, Vrtacnik Bokal E, Zorn B, Virant Klun I, Koster M, Liebenthron J, Nicolov A, van der Ven K, van der Ven H, Montag M, Fayazi M, Salehnia M, Beigi Boroujeni M, Khansarinejad B, Deignan K, Emerson G, Mocanu E, Wang JJ, Andonov M, Linara E, Ahuja KK, Nachef S, Figueira RCS, Braga DPAF, Setti AS, Iaconelli Jr. A, Pasqualotto FF, Borges Jr. E, Pasqualotto E, Borges Jr. E, Pasqualotto FF, Chang CC, Bernal DP, Elliott TA, Shapiro DB, Toledo AA, Nagy ZP, Economou K, Davies S, Argyrou M, Doriza S, Sisi P, Moschopoulou M, Karagianni A, Mendorou C, Polidoropoulos N, Papanicopoulos C, Stefanis P, Karamalegos C, Cazlaris H, Koutsilieris M, Mastrominas M, Gotts S, Doshi A, Harper J, Serhal P, Borini A, Guzeloglu-Kayisli O, Bianchi V, Seli E, Bianchi V, Lappi M, Bonu MA, Borini A, Mizuta S, Hashimoto H, Kuroda Y, Matsumoto Y, Mizusawa Y, Ogata S, Yamada S, Kokeguchi S, Noda Y, Shiotani M, Stojkovic M, Ilic M, Markovic N, Stojkovic P, Feng G, Zhang B, Zhou H, Zhou L, Gan X, Qin X, Shu J, Wu F, Molina Botella I, Lazaro Ibanez E, Debon Aucejo A, Pertusa J, Fernandez Colom PJ, Pellicer A, Li C, Zhang Y, Cui Y, Zhao H, Liu J, Oliveira JBA, Petersen CG, Mauri AL, Massaro FC, Silva LFI, Ricci J, Cavagna M, Pontes A, Vagnini LD, Baruffi RLR, Franco Jr. JG, Massaro FC, Petersen CG, Vagnini LD, Mauri AL, Silva LFI, Felipe V, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco Jr. JG, Vilela M, Tiveron M, Lombardi C, Viglierchio MI, Marconi G, Rawe V, Wale PL, Gardner DK, Nakagawa K, Sugiyama R, Nishi Y, Kuribayashi Y, Jyuen H, Yamashiro E, Shirai A, Sugiyama R, Inoue M, Salehnia M, Hovatta O, Tohonen V, Inzunza J, Parmegiani L, Cognigni GE, Bernardi S, Ciampaglia W, Infante FE, Tabarelli de Fatis C, Pocognoli P, Arnone A, Maccarini AM, Troilo E, Filicori M, Radwan P, Polac I, Borowiecka M, Bijak M, Radwan M. POSTER VIEWING SESSION - EMBRYOLOGY. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.79] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
48
|
Hochedez P, Hope-Rapp E, Olive C, Nicolas M, Beaucaire G, Cabié A. Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe. Am J Trop Med Hyg 2010; 83:1123-7. [PMID: 21036850 DOI: 10.4269/ajtmh.2010.10-0063] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Aeromonas species are Gram-negative bacilli of the water environment whose survival appears facilitated by warm climates. There have been no reports on Aeromonas species in the [corrected] Caribbean to date. Our aim was to describe clinical and bacteriological features in patients presenting with such bacteremia in Martinique and Guadeloupe. During a 14-year period, we retrospectively identified 37 patients. The mean age was 55 years and in 89% of cases underlying disease such as digestive diseases, cutaneous wounds, and malignancy were identified. One case was related to severe strongyloidiasis and one with snake bite. Polymicrobial bacteremia was identified in 38%, essentially with Enterobacteriaceae. All Aeromonas isolates were resistant to amoxicillin but extended-spectrum beta-lactam and fluoroquinolone were active against more than 95%. During hospitalization 10 patients died (27%). Older age, occurrence of multiorgan failure, and impaired renal function were associated with in-hospital mortality.
Collapse
Affiliation(s)
- Patrick Hochedez
- Department of Infectious and Tropical Disease, Fort de France Teaching Hospital, Martinique, France.
| | | | | | | | | | | |
Collapse
|
49
|
Gandois L, Nicolas M, VanderHeijden G, Probst A. The importance of biomass net uptake for a trace metal budget in a forest stand in north-eastern France. Sci Total Environ 2010; 408:5870-5877. [PMID: 20817222 DOI: 10.1016/j.scitotenv.2010.07.061] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2010] [Revised: 07/23/2010] [Accepted: 07/23/2010] [Indexed: 05/29/2023]
Abstract
The trace metal (TM: Cd, Cu, Ni, Pb and Zn) budget (stocks and annual fluxes) was evaluated in a forest stand (silver fir, Abies alba Miller) in north-eastern France. Trace metal concentrations were measured in different tree compartments in order to assess TM partitioning and dynamics in the trees. Inputs included bulk deposition, estimated dry deposition and weathering. Outputs were leaching and biomass exportation. Atmospheric deposition was the main input flux. The estimated dry deposition accounted for about 40% of the total trace metal deposition. The relative importance of leaching (estimated by a lumped parameter water balance model, BILJOU) and net biomass uptake (harvesting) for ecosystem exportation depended on the element. Trace metal distribution between tree compartments (stem wood and bark, branches and needles) indicated that Pb was mainly stored in the stem, whereas Zn and Ni, and to a lesser extent Cd and Cu, were translocated to aerial parts of the trees and cycled in the ecosystem. For Zn and Ni, leaching was the main output flux (>95% of the total output) and the plot budget (input-output) was negative, whereas for Pb the biomass net exportation represented 60% of the outputs and the budget was balanced. Cadmium and Cu had intermediate behaviours, with 18% and 30% of the total output relative to biomass exportation, respectively, and the budgets were negative. The net uptake by biomass was particularly important for Pb budgets, less so for Cd and Cu and not very important for Zn and Ni in such forest stands.
Collapse
Affiliation(s)
- L Gandois
- Université de Toulouse; UPS, INP; EcoLab (Laboratoire d'écologie fonctionnelle); ENSAT, Avenue de l'Agrobiopôle, F-31326 Castanet-Tolosan, France
| | | | | | | |
Collapse
|
50
|
Anel L, Gomes-Alves S, Alvarez M, Borragan S, Anel E, Nicolas M, Martinez-Pastor F, de Paz P. Effect of basic factors of extender composition on post-thawing quality of brown bear electroejaculated spermatozoa. Theriogenology 2010; 74:643-51. [DOI: 10.1016/j.theriogenology.2010.03.004] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2009] [Revised: 03/01/2010] [Accepted: 03/07/2010] [Indexed: 10/19/2022]
|